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Opportunistic infections with Mycobacterium tuberculosis and M. avium complex
(MAC) are common among HIV patients. This study used molecular typing
techniques on isolates from such patients, referred by laboratories in South East
England between 1991 and 1994, to investigate the epidemiology of these infections
within the region.
IS6110 restriction fragment length polymorphism analysis was satisfactory in terms of
typability, discriminatory power and reproducibility, for typing M. tuberculosis
isolates from 96 HIV patients and 84 controls. The viability of strains stored at room
temperature for more than two years was low, however. Isolates from HIV patients
were more often from extrapulmonary sites, compared to those from controls, and
resistance to antituberculous drugs occurred more frequently in the former.
Considerable heterogeneity was observed among the isolates from HIV patients,
reflecting the diverse origins of such patients living in the region. However, four
clusters of cases with indistinguishable strains were also detected, significantly more
than among the controls. This suggests that recently transmitted infection is
responsible for clinical disease more frequently among HIV patients, consistent with
findings elsewhere in the world. In one cluster, epidemiological information
supported the conclusion that nosocomial transmission of tuberculosis had occurred
from one patient to two others, and possibly to a healthcare worker. This was the
first outbreak of tuberculosis in an HIV care centre described in the United Kingdom.
Pulsed-field gel electrophoresis of Ase I large restriction fragments was a highly
discriminatory method for typing MAC isolates from 56 AIDS patients with
disseminated infection. Strains from different patients were markedly heterogeneous.
The majority of patients with infection at more than one body site, as well as those
with infection persisting for twelve months or more, had the same strain throughout.
A cluster of indistinguishable strains was observed, although insufficient
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1.1 MYCOBACTERIAL INFECTIONS IN HIV PATIENTS
Mycobacteria are the organisms most frequently responsible for opportunistic bacterial
infections in patients infected with human immunodeficiency viruses (HIV). This is
likely to be because effective defence against mycobacterial infection is dependent on
the function of activated macrophages. These cells are activated by cytokines
including interferon-gamma, produced by T-helper (Th-1) lymphocytes in response to
the presentation of mycobacterial antigens. Many changes in the immune system
occur as a consequence of HIV infection, including alteration in the balance of
endogenous cytokines (Fauci et al. 1996), reduced macrophage function, and gradual
depletion of the number and function of CD4 + lymphocytes, especially the Th-1
subset. These changes adversely affect the ability to overcome infection by
mycobacteria. Furthermore, as the CD4 + lymphocyte count gradually declines,
different clinical patterns of mycobacterial infection are encountered (Lucas & Nelson
1994). Thus, when cell mediated immunity is still relatively intact pulmonary
tuberculosis may be seen, whereas extrapulmonary disease is more characteristic of
later stages. Miliary tuberculosis and disseminated infection with atypical
mycobacteria usually occur only when the CD4 + count has fallen to very low levels.
As the total number of HIV seropositive persons has risen since the early 1980s, the
isolation of mycobacteria from this group has also increased (Horsburgh & Selik
1989, Yates et al. 1993, Benson 1994, Taylor et al. 1995). Many species of
mycobacteria have been found to cause disease in HIV patients. These include
Mycobacterium kansasii (Carpenter & Parks 1991, Witzig et al. 1995), which may be
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responsible for localised pulmonary disease or disseminated infection, M. xenopi, "\1.
fortuitum (Shafer & Sierra 1992), M. cheIonei, M. haemophilum (Chin 1993), M.
maimoense, M. genavense (Bottger et aI. 1992, Maier et ai. 1995) and M. ceIatum
(Piersimoni et al. 1994). By far the most important, however, are M. tuberculosis
and M. avium. In addition, new patterns in the presentation and epidemiology of
mycobacterial infections have become apparent. For example, outbreaks of
tuberculosis, often with accelerated progression of disease in those affected and
sometimes involving multidrug resistant strains, have been particularly associated with
HIV groups; disseminated infection with M. avium complex (MAC) is common in
patients with acquired immunodeficiency syndrome (AIDS) but extremely rare in other
patients.
At the same time that these challenging clinical problems have emerged, new
molecular biological techniques have been developed and have been applied to typing
the organisms responsible. The results of these studies are giving new insight into
the epidemiology of these infections.
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1.2 MYCOBACTERIUM TUBERCULOSIS
1.2.1 Trends in tuberculosis notifications and the contribution of HIV co-
infection
Tuberculosis, that is, active clinical disease following M. tuberculosis infection,
remains one of the most common fatal infectious diseases of man. In the last ten
years the reversal of the steady decline in tuberculosis seen in the developed and parts
of the developing world has been a matter of great concern (Bloom & Murray 1992,
Horsburgh & Pozniak 1993, Dttley & Pozniak 1994). The World Health Organisation
(WHO) estimated that in 1990 there were eight million new cases of tuberculosis and
nearly three million deaths; notifications rose by 24.6% compared to the averages of
the mid 1980s (WHO 1992). HIV infection is the most important risk factor for
tuberculosis (Styblo & Enarson 1991, Horsburgh & Pozniak 1993, Haas & Des Prez
1994, Schulzer et al. 1994). The relative risk of developing tuberculosis following
infection with M. tuberculosis is 170.3 for patients with AIDS, compared to 30 for
those with silicosis and 11.9 for patients on immunosuppressive treatment (A.
Pozniak, personal communication). Although its role varies from one part of the
world to another, HIV is partly responsible for recent changes in tuberculosis
epidemiology.
Developing coulltries
The association between HIV and the observed increase in tuberculosis is strongest in
developing countries. The annual risk of infection with M. tuberculosis is highest in
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sub-Saharan Africa where the majority of clinical cases are under 50 years of age
(Kumar & Watson 1994). This is the same population that is at risk of HIV infection
through predominantly heterosexual spread, and studies have shown that the
seroprevalence of HIV in patients presenting with clinical tuberculosis is up to 60 %
(Harries 1990, Elliott et al. 1993, van den Broek et al. 1993, Houston et al. 1994,
Richards et al. 1995, van Cleeff & Chum 1995). HIV is becoming more common in
the Indian subcontinent and Southeast Asia, where a significant proportion of global
tuberculosis cases occur. There is evidence of a rising trend of HIV infection in
patients with pulmonary tuberculosis in India (Solomon et al. 1995) and the potential
exists for a crisis in tuberculosis control in that part of the world (WHO 1994).
United States of America
In the United States reported cases of tuberculosis decreased from the 1950s until the
mid 1980s. Between 1985 and 1992 however the number increased again by nearly
20 %, resulting in an estimated 63000 excess cases over the number expected had the
trend from 1980 to 1984 continued (Centers for Disease Control 1993). Much of the
increase occurred in young adults living in inner city areas and has been attributed to
a large extent to tuberculosis in patients coinfected with HIV. Analysis of matching
cases of tuberculosis and AIDS reported to Centers for Disease Control, Atlanta
suggested that at least 30% of the excess cases of tuberculosis during the period 1985-
90 are attributable to HIV-induced immunosuppression (Burwen et al. 1995).
Although there is evidence of considerable overlap between tuberculosis and HIV in
New York City (Greenberg et al. 1995), other factors have also played an important
part in contributing to the rise: homelessness and overcrowding in inner city areas.
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intravenous drug use, increased immigration from countries with a high prevalence of
tuberculosis, and a decline in resources for tuberculosis control programmes (Snider &
Roper 1992).
Western Europe
Notifications of tuberculosis have continued to decline in some Western European
countries, whereas in others they have levelled off or increased, for example in
Ireland, Italy and the Netherlands (Raviglione et al. 1993). In general HIV appears to
have had only a marginal effect on this trend, although it may be more important in
the Paris area and among groups of HIV patients in Italy and Spain. A multicentre
European study that reviewed 6572 patients diagnosed with AIDS between 1979 and
1989 found that extrapulmonary tuberculosis was much more frequent in Southern
Europe than in Central or Northern regions, either at the time of the AIDS diagnosis
or at subsequent follow-up (AIDS in Europe, 1996). For other European regions,
demographic changes in the populations, with increasing numbers of elderly persons
who are liable to reactivation of infection acquired earlier in life, and an increase in
the number of immigrants from areas with a high prevalence of tuberculosis have been
responsible for these changes (Raviglione et al. 1993, Liard et al. 1994).
United Killgdoll1
Although deaths from tuberculosis in England and Wales reported to the Office of
Population Censuses and Surveys have continued to decline in the last thirty years, the
total number of notifications of tuberculosis has risen slightly since 1987. In that year
5086 cases were notified in England and Wales, compared to 5799 in 1992 and
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(provisionally) 6052 in 1993. Notification rates were highest in the elderly. especially
in men (Kumar & Watson 1994). The increase is most marked in London, where
notified cases of tuberculosis rose from 21 to 31 per 100000 between 1987 and 1994.
37 % of all cases in 1994 were in London residents, who make up 13 % of the
population of England and Wales (Communicable Disease Surveillance Centre 1996a).
A survey of notifications carried out in 1988 showed that the rate in immigrants
originating from the Indian subcontinent was nearly 25 times that in the white
population and accounted for 39 % of all notifications (Medical Research Council
Cardiothoracic Epidemiology Group 1992). It is unlikely that HIV played a
significant role in cases of tuberculosis in Britain during this period because the
overlap between those seropositive for HIV, mostly young white men, and those with
previous tuberculous infection, mostly the elderly and those from the Indian
subcontinent, was small (Watson & Gill 1990, Watson 1993, Watson et ai. 1993).
Such an overlap is mainly limited to immigrants from sub-Saharan Africa. A further
survey of notifications of cases of tuberculosis was carried out by the Communicable
Disease Surveillance Centre (CDSC) of the Public Health Laboratory Service in
collaboration with the British Thoracic Society and Department of Health in 1993. As
part of the survey the prevalence of HIV infection was estimated in cases aged 16 to
54 years by unlinked anonymous HIV testing. About 40% of those eligible were
tested and the prevalence of HIV infection in this group was approximately 2 %
(Communicable Disease Surveillance Centre 1994). These preliminary results may be
an underestimate of the true prevalence of HIV infection in patients with tuberculosis
notified in 1993, but confirm that HIV plays only a small part in the epidemiology of
tuberculosis in England and Wales at present. Other factors for the increase are
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therefore likely to be involved. Tuberculosis is known to be common among the
homeless, whose numbers have increased in recent years. A survey at a temporary
shelter for the homeless in London at Christmas 1992 confirmed this to be the case
(Kumar et al. 1993). However, many patients in this group are unlikely to reach
medical attention and to be notified. Another possibility is an increase in cases in
recent immigrants to the United Kingdom: the 1993 national survey showed a
significant rise in cases among those of black African origin. A review of African
AIDS patients in London between 1982 and 1995 found that tuberculosis was much
more common among African than non-African patients, accounting for 27% of initial
episodes of AIDS in Africans compared to 5 % in non-Africans. The incidence of
tuberculosis in patients with another AIDS-indicator disease was also higher among
Africans: 16 (versus 6) per 100 person-years (Del Amo et al. 1996). The median stay
in the United Kingdom among African patients in this study from whom information
was available was only 12 months. In Hackney, East London, however, tuberculosis
in recently arrived immigrants accounted for less than half of the increase in
notifications between 1986 and 1993 (Bhatti et al. 1995). Demographic changes
leading to reactivation of old infection in the increasing elderly population, and an
improvement in notification rates, associated with the creation of the role of
Consultant in Communicable Disease Control in 1988 are also possible contributing
factors. Two recent studies however suggest that the most important contributory
factor for the increasing incidence of tuberculosis is socioeconomic deprivation. In
England and Wales between 1980 and 1992 an increase occurred only in the poorest
30% of the population and was greatest in the poorest 10% (Bhatti et al. 1995,
Mangtani et al. 1995).
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1.2.2 Tuberculosis in patients with HIV infection
Persons infected with HIV are at increased risk of tuberculosis in two ways.
Reactivation of latent tuberculous infection becomes more likely as the number of
functioning CD4 lymphocytes is progressively depleted as a result of HIV. For
example, in a prospective study of intravenous drug users in N,ew York whose
tuberculin sensitivity (an indicator of previous infection with M. tuberculosis) and HIV
status were known, it was shown that the rate of tuberculosis in the HIV-seropositive
cohort was 7.9 per 100 person years in those who were initially tuberculin pasitive
compared to 0.3 per 100 person years in those who were tuberculin negative. The
rate of conversion from negative to positive tuberculin sensitivity was similar for both
HIV positive and negative subjects during the study (Selwyn et al. 1989). A similar
relationship between incidence rate of tuberculosis and tuberculin skin test reactivity in
Italian HIV infected patients was reported by Antonucci et aI. (1995), who also
demonstrated increasing incidence of tuberculosis with declining CD4 lymphocyte
count. Secondly, because of impaired cell-mediated immunity, HIV patients who have
not previously been infected are more likely to develop active primary tuberculosis if
exposed to tubercle bacilli. Thus, in an outbreak of tuberculosis in a housing facility
for HIV patients in San Francisco 15 out of 30 residents exposed to a source were
infected and in 11 of these (37 %) infection rapidly progressed to active disease. By
comparison, none of the staff members exposed to the same source developed active
tuberculosis although some had positive tuberculin tests (Daley et aI. 1992).
Although tuberculosis may occur at any stage during the course of HIV infection it is
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more often seen in the later stages (Girardi et al. 1994). The likely clinical and
radiographic manifestations differ considerably as the CD4 cell count progressively
declines. Typical features of post-primary pulmonary tuberculosis such as upper lobe
disease with cavitation are more often seen in patients at an early stage of HIV
infection when the CD4 count is still high. As immunodeficiency worsens, lower
zone infiltration, thoracic lymphadenopathy, as well as extrapulmonary disease and
disseminated infection with mycobacteraemia are more common. Conversely, features
that result from delayed hypersensitivity such as tuberculous pleural effusion and a
positive tuberculin skin test are often absent with low CD4 cell counts (Barnes et al.
1991, Barnes et al. 1993 , Jones et al. 1993, Given et al. 1994, Post et al. 1995,
Daley et ai. 1995). Tuberculosis in patients with HIV-2 infection gives rise to clinical
features similar to those seen in HIV-1 co-infection (Gnaore et al. 1993). The
evidence from developing countries is that patients with HIV and pulmonary
tuberculosis are not more infectious to others than seronegative tuberculosis patients
(Elliott et al. 1993b, Nunn et al. 1994).
The interrelationship between HIV and M. tuberculosis co-infection may also result in
accelerated progression of HIV disease. Experiments in human monocyte cell lines
infected with HIV have shown that phagocytosis of M. tuberculosis or of its purified
protein derivative enhances transcription of integrated provirus genes, although release
of intact HIV from such cells may not be increased (Lederman et al. 1994, Shattock
et al. 1994). Similarly, activation of HIV-infected T lymphocytes and macrophages
by M. tuberculosis enhances release of tumour necrosis factor-a and B2-microglobulin.
which may lead to increased HIV expression (Wallis et al. 1993). Goletti et al.
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(996) have demonstrated that active tuberculosis increases HIV replication in ~'il'o, as
shown by a 5 to 160-fold increase in levels of plasma viraemia during the acute phase
of disease which subsequently returns to baseline levels after successful treatment.
These authors also showed that viral replication increased in response to M.
tuberculosis in an in vitro model, and concluded that activation and infection of
CD4+ T cells responding to the mycobacterial challenge are most likely to be
responsible for increased viral production.
Two important factors associated with tuberculosis in HIV patients, particularly seen
in the United States, are the occurrence of outbreaks of infection in hospitals and
other settings and the emergence of multiply drug-resistant strains of M. tuberculosis.
Nosocomial transmission of tuberculosis on a ward for HIV patients in Verona, Italy
was first described by di Perri et al. in 1989. Subsequently, many hospital outbreaks
have been recognised, especially in Florida and New York (Centers for Disease
Control 1991a, Beck-Sague et al. 1992, Edlin et al. 1992, Pearson et al. 1992, Barnes
et al. 1993, Coronado et al. 1993). Transmission of M. tuberculosis between HIV
patients in hospital may be facilitated when diagnosis and treatment are delayed
because of failure to recognise atypical presentations of tuberculosis in this group. In
addition, when procedures which induce coughing such as sputum induction,
bronchoscopy and administration of nebulised drugs are carried out in conditions with
inadequate ventilation the concentration of infectious droplet nuclei in the air is
increased. Lack of appropriate isolation facilities for tuberculosis patients in some
units nlay exacerbate the problem (Snider & Roper 1992). Outbreaks of tuberculosis
among HIV patients have also occurred in prisons (Valway et al. 1994), in residential
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facilities (Daley et ai. 1992), and in shelters for the homeless (Centers for Disease
Control 1991b). Transmission to health care workers and to prison staff, who may be
seronegative for HIV, is well recognised.
Many of the strains of M. tuberculosis identified in these epidemics have been
multiply drug resistant (Snider & Roper 1992, Barnes et ai. 1993, Haas & Des Prez
1994), that is resistant to at least two antituberculous drugs including rifampicin and
isoniazid. Strains resistant to up to seven drugs have been isolated. Most modern
regimens which are effective for treating susceptible strains employ rifampicin,
isoniazid and pyrazinamide. Other antituberculous drugs are often difficult to
administer and/or commonly cause serious adverse effects, particularly in AIDS
patients. When first recognised, the mortality of multidrug resistant tuberculosis
(MDRTB) was between 70 and 90%. In one hospital the median time from diagnosis
to death was 2. 1 months compared to 14.6 months in HIV seropositive patients with
tuberculosis caused by drug sensitive strains (Fischl et ai. 1992). Delay in
recognising infection caused by a multidrug-resistant strain, partly due to the long
interval of 4 to 11 weeks required for primary isolation of the organism from a
clinical specimen followed by susceptibility testing by conventional methods,
contributes to the high mortality of this infection. Furthermore, patients treated with
an inappropriate regimen until susceptibility results are available may continue to
transmit the resistant strain to others. More recent reports however, suggest that
inlproved clinical outcomes for patients with MDRTB can be achieved, particularly if
disease is recognised early and at least two drugs to which the initial isolate is
susceptible in vitro are promptly administered (Salomon et ai. 1995, Turett et al.
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1995).
Great efforts have been made to control the spread of MDRTB among HIV patients
and healthcare workers in the United States. Guidelines for limiting spread of
airborne pathogens published by the Centers for Disease Control (CDC) in 1990 and
1994 include recommendations for negative pressure ventilation, high efficiency
particulate air filtration, germicidal UVA irradiation of the air supply and use of high
efficiency respirators by staff. These measures are expensive to implement, and
respirators in particular are unpopular with healthcare workers and of doubtful cost-
effectiveness (Adal et al. 1994). Nevertheless, effective control of nosocomial
transmission of MDRTB has been demonstrated in a Florida hospital by
implementation of these measures (Wenger et ai. 1995). Transmission of MDRTB
among AIDS patients in a hospital in New York City also decreased markedly when
CDC guidelines were implemented (Stroud et ai. 1995). The greatest change was
observed after enforcement of simple administrative measures, such as isolating
patients with suspected tuberculosis in side rooms, before engineering changes
(improved ventilation to the rooms) were made. Infection among staff, as judged by
tuberculin skin test conversion rate also fell when CDC guidelines were put into
practice at aNew York hospital. The decrease, from 20.7 % to 5.8 % between 1991
and 1993, occurred before the introduction of high efficiency particulate air filter
respirators (Fella et al. 1995).
It is likely that MDRTB originated under the selective pressure of inadequate
chemotherapy because of inappropriate selection of therapy and poor compliance by
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some patients (Riley 1993). In New York City where most cases of MDRTB have
occurred, dismantling of an effective tuberculosis control program (chest clinics.
patient home visits, etc.), non-compliance with medication (86% of patients starting
antituberculous therapy were lost to follow-up or failed to complete therapy in one
study (Brudney & Dobkin 1991)), worsening socioeconomic conditions such as
homelessness, and HIV infection have all contributed to this major public health
problem. The restoration of tuberculosis control programs, and especially use of
directly observed therapy, is helping to reverse the trend (CDC 1995). Evaluation of
suitable drug regimens for patients with multidrug-resistant strains (Iseman 1993), and
the development of more rapid methods for the detection of M. tuberculosis in clinical
specimens and for susceptibility testing, including use of molecular biological methods
(Drobniewski et al. 1994), will facilitate the management of patients with MDRTB.
1.2.3 Typing methods for Mycobacterium tuberculosis
The study of tuberculosis epidemiology has been greatly enhanced in recent years by
the development of molecular methods of typing M. tuberculosis which are capable of
typing nearly all strains and of reproducibly distinguishing between them with great
discriminative power. Such methods allow outbreaks of tuberculosis to be traced
precisely and on a larger scale may be applied to cases in populations in order to
monitor patterns of disease transmission, for example the relative contributions of
exogenous infection and reactivation.
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Previously, methods based on phenotype were used with limited success in an attempt
to distinguish different isolates of M. tuberculosis. Phage typing was available but
little used because of limited discriminative power, technical difficulty and poor
reproducibility between laboratories (Rado et al. 1975). Larger numbers of phages
would be required to improve discriminative power but standardisation of phage
stocks remains a problem. Multilocus enzyme electrophoresis has also been applied to
mycobacteria, but the method was technically demanding and found members of the
M. tuberculosis complex to be genetically homogeneous, supporting the concept of a
single species (Wasem et al. 1981, Feizabadi et al. 1996). High performance liquid
chromatography which analyses mycolic acids of the mycobacterial cell wall is able to
distinguish different species of mycobacteria and to some extent between strains of M.
tuberculosis (Butler et al. 1991). Again, its limited discriminative power is not good
enough for epidemiological purposes. Alternatives to methods based on phenotype are
therefore required.
Restriction fragment length polymorphism analysis
Genotypic methods of distinguishing strains of M. tuberculosis employ restriction
endonucleases which cut chromosomal DNA at specific sites to exploit slight
differences in DNA sequences between strains that do not give rise to differences in
phenotype. Restriction fragments thus produced may be separated by gel
electrophoresis and visualised directly by ethidium bromide staining. This simple
approach is not very useful for M. tuberculosis however, as the patterns produced are
very complex and relatively homogeneous (Shoemaker et al. 1986). Better results
have been obtained when high molecular weight fragments, produced with restriction
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endonucleases that cut genomic DNA infrequently, are separated by pulsed-field gel
electrophoresis (see section 1.3.6). In this way Zhang et al. (1992) were able to
separate 26 isolates of M. tuberculosis into 10 clusters of related isolates. The
isolates within each cluster yielded indistinguishable large restriction fragment patterns
and the grouping into clusters was confirmed by hybridisation with a labelled probe to
IS6110.
An alternative technique for analysis of the variation in the position of the restriction
enzyme cutting sites (restriction fragment length polymorphism, RFLP) is to transfer
the DNA fragments after electrophoresis to a suitable membrane by Southern blotting
and then to hybridise with a labelled probe of a selected repetitive element. This
allows detection of the fragments of different sizes which possess copies of the
appropriate repetitive element. A characteristic RFLP pattern or 'fingerprint' is
generated for each strain. Probes to ribosomal RNA genes have been used for many
bacterial species since such genes are usually present in multiple copies and their
sequence is highly conserved. However, ribotyping is unsuitable for M. tuberculosis
since this species has only a single copy of rRNA genes which would give inadequate
polymorphism.
Insertion sequence 186110 and its role in studies of molecular epidemiology
Insertion sequences are suitable repetitive elements for use as probes in RFLP analysis
because they are usually present in multiple copies and are mobile throughout the
genOInic DNA to a greater or lesser extent giving rise to polymorphism of position.
They characteristically contain short inverted terminal repeat sequences and genes
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coding for proteins involved in transposition. The insertion sequence 156110 has been
the one used most widely in studies of M. tuberculosis to date. IS6110 was sequenced
by Thierry et al. (1990a,b) and shown to be related to the IS3 family of insertion
sequences found in the Enterobacteriaceae. Two other insertion sequences, IS986,
isolated from a M. fortuitum plasmid (Zainuddin & Dale 1989, McAdam et al. 1990),
and IS987 from a strain of M. bovis BCG (Hermans et al. 1991), have sequences
which differ from IS6110 by only a few base pairs and can be considered as
essentially the same element. IS6110 is 1355 base pairs in length and contains a single
restriction site for Pvu II at base pair 461 (Figure 1.2. 1). It is very well suited to
typing studies of M. tuberculosis because it is confined to the M. tuberculosis
complex, is present in almost all strains usually in multiple copies, and is distributed
throughout the genome with considerable polymorphism between strains. At the same
time, the location of IS6110 in the genomes of different strains is very stable: repeated
in vitro cultures or animal passages do not generally result in changes in its
distribution (van Soolingen et al. 1991). Fingerprint patterns of repeated isolates
recovered from individual patients during intervals of up to four and a half years
remain identical or virtually identical (Otal et af. 1991, Cave et af. 1994). A
standardised methodology for RFLP analysis of M. tuberculosis has been proposed to
facilitate comparison of results between different groups. This uses the restriction
endonuclease Pvu II and a DNA probe which hybridises to a fragment of IS6110 to
the right of this restriction site (van Embden et af. 1993).
This method has been extremely valuable in epidemiological investigations of
outbreaks of tuberculosis: isolates from epidemiologically linked cases have
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Map of the insertion el,ement 186110 of M. tuberculosis
The insertion element is 1355 base pairs in length, and is bordered by 28 base pair
inverted repeats (shaded). The cleavage sites of several restriction enzymes are
shown, including Pvu II which cleaves at base pair 461. A DNA probe to the right of
this restriction site as shown is used in the standardised methodology for RFLP
analysis of M. tuberculosis.
Based on van Embden et al. (1993).
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indistinguishable or very closely related banding patterns, whereas unrelated isolates
show great diversity (Hermans et aZ. 1990, CDC 1991, van Soolingen et aZ. 1991.
Beck-Sague et aZ. 1992, Daley et al. 1992, Edlin et al. 1992, Godfrey-Faussett et af.
1992, Coronado et al. 1993, Valway et al. 1994). When multiple isolates are
available from patients with recurrent tuberculosis it is also possible to distinguish
relapse of the original infection from reinfection with a different strain, as shown by
studies in Hong Kong (Das et aZ. 1993) and of HIV patients in Kenya (Godfrey-
Faussett et al. 1994) and Switzerland (Strassle et aZ. 1997). RFLP analysis with
IS6110 has also been used in individual cases to demonstrate that acquired resistance
to rifampicin in M. tuberculosis does not modify the DNA fingerprint (Godfrey-
Faussett et al. 1993, Strassle et af. 1997).
An important application of RFLP analysis using IS6110 is to the study of tuberculosis
epidemiology in large communities. Typing all isolates from each confirmed case of
tuberculosis in a defined area over a period of time allows an assessment of the degree
of heterogeneity of the strains causing disease in that area. It is believed that the
degree of heterogeneity reflects the relative proportions of cases that are due to recent
transmission of M. tubercuZosis or to relapse of old previously acquired infection.
Such studies may also disclose previously unrecognised outbreaks of infection in the
community (Table 1.2.1).
Less heterogeneity among strains is expected in countries with high rates of
tuberculosis or when tuberculosis has only been in a community for a short time. In
such circumstances most cases follow recent transmission of the organism. This was
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Table 1.2.1 Summary of published community studies of tuberculosis
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Less polymorphism among African strains
than those from the Netherlands; inversely
related to rate of TB in the community
18 pairs of isolates among 92 patients
101 different strains among 134 patients.
No difference between HIV positive and
negative patients.
Much less heterogeneity of strains in one
district compared to 3 others. Degree of
polymorphism is related to the stability of
the population.
Up to 40 % of cases are part of a cluster.
HIV infection, poverty, infection with a
drug resistant strain increase chance of being
in a cluster. Few clusters were recognised
by conventional contact tracing.
Community outbreak among 6 HIV patients,
not recognised by contact tracing.
45 out of 163 patients were potentially
linked. Complex network of transmission,
largely between native young adults. Only
apparent from RFLP analysis of strains.
Despite low endemicity of TB, recently
transmitted infections comprise at least a
quarter of all cases. Chains of transmission
in specific regions were recognised.
Significant active transmission (11 clusters
among 64 patients) occurred in a stable
population with a low incidence of TB.
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confirmed by van Soolingen et al. (1991) who showed a lesser degree of
polymorphism among African strains than in those collected in the Netherlands.
Another study in Malawi and Kenya (Godfrey-Faussett & Stoker 1992) demonstrated
18 matched pairs of isolates from 92 patients, although no epidemiological links
between patients were found. It was nevertheless concluded that heterogeneity
amongst strains was sufficient to allow valid molecular epidemiological study of
tuberculosis in Africa. Similarly, in Tanzania, a country with high rates of both
tuberculosis and HIV, 101 different IS6110 fingerprint patterns were observed among
134 patients with tuberculosis, half of whom also had HIV infection (Yang et al.
1995b). The level of diversity in HIV seropositive and negative groups was
comparable, suggesting, in this population, an equal risk of infection with a defined
M. tuberculosis clone regardless of HIV status. However, patterns of tuberculosis
transmission appear more complex when examined at a local level. For example, four
districts in North Tunisia gave contrasting results when M. tuberculosis strains
isolated over a three year period were examined (Chevrel-Dellagi et al. 1993).
Strains from three districts displayed a high degree of polymorphism whereas those
from the district of Menzel Bourguiba were much less heterogeneous, with 58 % of
cases in that area traceable to four M. tuberculosis strains. It was suggested that the
degree of polymorphism may be related to the stability of the population: higher
diversity is expected in large cities or regions with mixed populations because strains
are imported from different geographical areas.
In the United States it was assumed until recently that about 90% of active cases of
tuberculosis resulted from reactivation of previously acquired infection (Hamburg &
31
Frieden 1994). The results of typing studies from New York City (Alland et al.
1994) and San Francisco (Small et al. 1994) however have challenged this view. In
the former, 104 patients treated for tuberculosis at a Bronx hospital benveen 1989 and
1992 had complete medical records and isolates whose RFLP patterns were evaluable.
37.5 % of these had patterns identical to at least one other patient; overall, 12 clusters
of cases were recognised. The San Francisco study examined the RFLP patterns of
strains from patients reported to that city's tuberculosis registry in 1991-92. 191
(40 %) of 473 patients evaluated belonged to one of 44 clusters of identical patterns,
which were between 2 and 30 persons in size. However, conventional contact tracing
only identified links among ten percent of the patients, illustrating the power of this
molecular epidemiological tool. In both studies it was assumed that clusters of cases
with similar strains result from recent transmission of infection. Risk factors for
belonging to a cluster were found to be HIV infection, black race or Hispanic
ethnicity (socioeconomic factors rather than genetic predisposition may be more
relevant) and infection with a drug resistant strain (as such patients are usually
infectious to others for longer). In contrast, older patients and those born abroad
were less likely to belong to a cluster, suggesting that reactivation of old infection was
the cause of their disease. It is surprising however, that the proportion of cases due
to recent transmission was similar in the two cities, when the proportion of patients
completing therapy at that time was much higher in San Francisco than in New Yark
City (Hamburg & Frieden 1994).
The strong link between HIV and recently transmitted infection, (nearly two thirds of
HIV seropositive patients were part of a cluster), was also found in a study of
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community-acquired tuberculosis in King County, Washington, USA (Tabet et al.
1994). RFLP analysis on isolates from 18 HIV positive patients and 10 without risk
factors for HIV revealed a community outbreak of tuberculosis affecting 6 HIV
positive patients whose only common exposure was contact at one or more of three
bars. Again, this outbreak was revealed only when RFLP analysis on stored strains of
M. tuberculosis was performed and had not previously been detected by conventional
contact tracing.
Evidence that tuberculosis is spreading in parts of Europe in ways similar to those
seen in the United States was obtained from a population study in Berne, Switzerland,
in which all isolates from culture positive cases during 1991-92 were examined by
RFLP analysis with an 156110 probe (Genewein et ai. 1993). 45 of the 163 patients
were potentially linked on this basis. Epidemiological investigation uncovered a group
of 22 patients which included drug addicts, alcoholics and homeless persons from
whom tuberculosis spread to the general population. A complex network pattern of
transmission was observed which was not identifiable by conventional contact tracing.
Transmission in the native population occurred largely between young adults, whereas
tuberculosis in immigrants, although responsible for a large proportion of cases, did
not spread to the general population. Furthermore, the group in which tuberculosis
was mainly transmitted - i. v. drug users, HIV positive persons and the homeless - is
the one most susceptible to the development of drug resistance because of poor
compliance with therapy. Multidrug resistance was observed to develop in one case
in this study.
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Community studies on RFLP analysis of M. tuberculosis in other countries with a low
incidence of tuberculosis have also revealed unexpectedly high proportions of cases
due to recent transmission of infection. In Denmark, a country with a well
established tuberculosis control programme and low endemicity of tuberculosis,
recently transmitted infections comprised at least a quarter of all cases in 1992, and
chains of transmission in specific geographical regions were identified (Yang et al.
1995a). However, no data were available on the HIV status of patients involved in
these clusters, as the collection of such information is restricted by Danish law. This
study also showed that while nearly half of the cases of tuberculosis involved patients
of foreign origin, most of these had unique RFLP patterns and were rarely part of
active chains of transmission. The authors suggested that clinical suspicion of
tuberculosis in native Danish patients with pulmonary symptoms is lower than for
immigrants, so that delay in diagnosis and treatment in the former may lead to further
transmission of infection. A study in French Polynesia (Torrea et al. 1995), where
there is a low incidence of tuberculosis in a geographically stable population, has also
suggested that active transmission of infection occurs to a significant extent in that
community. 38 different IS6110 types were found among isolates from 64 patients
which clustered in 11 groups.
As outlined above, RFLP analysis using IS6110 has been the most widely used
molecular typing method for M. tuberculosis to date and has greatly contributed to our
understanding of the epidemiology of infection caused by this organism (Hayward
1995). A limitation of the method, however, is its restricted ability to distinguish
between the minority of strains which carry only one or two copies of IS6110.
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Strains with only one copy are more common in certain populations, including those
from South India, where they accounted for the isolates from 40 % of patients (Das er
al. 1995), Vietnam (Yuen et al. 1993), Malaysia, Tanzania and Oman (Fomukong er
al. 1994). As in most strains of M. bovis BeG, which usually have a single copy of
IS6110, the insertion sequence appears to be located in a specific region of the
chromosome which may represent a 'hot spot' for IS6110 integration (Hermans et al.
1991, van Soolingen et al. 1993a). An alternative explanation put forward by
Fomukong et al. (1994) is that IS6110 may be defective in transposition in these
strains and the loss of transposability may have occurred at an early stage in the
evolution of the M. tuberculosis complex.
Recently, a 267-nucleotide genomic region which is able to carry IS6110 at six
alternative locations (the IS6110 preferential locus, ipl) has been described (Fang &
Forbes 1997). As these authors point out, if IS6110 insertion occurs in such preferred
regions of the chromosome rather than at random, then the variety of RFLP patterns
produced will be diminished, so that the discriminatory power of this typing method is
inversely proportional to the ratio of preferred to random IS6110 insertion sites.
Rarely, strains of confirmed M. tuberculosis have been encountered from India and
Vietnam that lack IS6110 altogether (van Soolingen et al. 1993a, Yuen et al. 1993,
Das et al. 1995). IS6110 RFLP analysis is therefore unsuitable as a tool for
epidemiological studies in areas where such strains are prevalent. These strains would
also give false negative results in diagnostic tests for M. tuberculosis in clinical
specimens based on polymerase chain reaction amplification and DNA hyhridisation
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methods directed towards IS6110.
Other repetitive DNA elements
Other repetitive elements have been evaluated as potential targets for genotypic typing
methods (Table 1.2.2).
Table 1.2.2 Repetitive DNA elements in M. tuberculosis
Element Size (bp) Host range Copy no. Suitability for RFLP
analysis
IS6110 1355 MTBC 0-25 Widely used
IS1081 1324 MTBC, 5-7 Insufficient
M. xenopi polymorphism
MPTR 10 MTBC, > 100 Low discrimination
M. kansasii, Not often used
M. gordonae,
M. szulgae, etc.
PGRS 30 MTBC > 100 Highly discriminatory
Very complex patterns
DR 36 MTBC 10-50 Useful to distinguish
strains with similar low
copy IS6110 patterns
Abbreviations: MPTR major polymorphic tandem repeat
PGRS polymorphic GC-rich repetitive sequence
DR direct repeat sequence
MTBC M. tuberculosis complex
Data from Small & van Embden (1994) and van Soolingen et al. (1993a).
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IS1081 is a 1324 base pair insertion sequence originally identified in the genome of
M. bovis (Collins & Stephens 1991) which is virtually exclusive to members of the M.
tuberculosis complex (van Soolingen et al. 1992). Most strains carry five or six
copies of IS1081 but unfortunately the sites of insertion of these appear to be highly
conserved giving rise to very limited polymorphism between different strains, so that
this insertion sequence is not suitable for use in epidemiological investigations (van
Soolingen et ai. 1992, Collins et al. 1993). It may however be possible to distinguish
M. bovis BCG from other M. tuberculosis complex strains by the presence in the
former of an 8.0 kilobase IS1081-containing Pvu II fragment (van Soolingen et al.
1992).
Several repetitive DNA elements which are not insertion sequences have also been
investigated with regard to potential use in typing. These are (i) the major
polymorphic tandem repeat sequences, consisting of a tandemly-repeated unit of ten
base pairs with copies separated by five base pair unique sequences (Hermans et al.
1992), (ii) a polymorphic GC-rich repetitive sequence (Ross et al. 1992), and (iii) the
direct repeat sequences, which are 36 base pair sequences found in multiple copies at
the 'hot spot' for 156110 integration into the chromosome (Hermans et al. 1991). A
study of strains containing only one copy of IS6110, or two copies at the same
chromosomal locus, found that RFLP patterns obtained with a probe to the major
polymorphic tandem repeat on Alu 1 digested DNA gave insufficient discrimination to
be useful. Hybridisation of a probe to the GC-rich repetitive sequence carried on
plasmid pTBN12 with the same DNA samples gave highly discriminatory results but
the patterns obtained were complex and difficult to interpret. The best results were
37
found with a probe to the 36 base pair direct repeat region on Alu 1 digested DNA,
which was able to distinguish most of the strains that had very similar IS6110 RFLP
patterns (van Soolingen et ai. 1993). This method, direct repeat (DR) RFLP analysis.
was successfully used in the molecular epidemiological study of tuberculosis in New
York (Alland et al.1994) to sort strains with two identical bands on hybridisation with
156110 into three smaller clusters. In the French Polynesian study (Torrea et al.
1995) DR RFLP was able to confirm the relationship between strains with similar
IS6110 RFLP types and also showed two clusters of strains with different 156110
patterns and the same DR RFLP type, suggesting that the two clusters may have
shared a common origin and evolved to new 156110 types. The combination of RFLP
analysis with probes to IS6110 and to the DR region may prove to have even greater
value in tracing the spread of M. tuberculosis through communities than the use of
IS6110 alone. The conclusion that additional genotyping markers are required to
enhance accuracy in epidemiological work was also reached in a study of highly
polymorphic genomic domains of M. tuberculosis which hybridise to the
oligonucleotide (GTG)s (Warren et ai. 1996). Probes to these genomic domains were
used to genotype strains of M. tuberculosis with indistinguishable IS6110 fingerprints
isolated in a South African community. The method was able to subclassify 156110
clusters, including those with a high copy number of IS6110, into smaller clusters and
unique strains. Significantly, the molecular data correlated with patient interviews and
clinical records, as contacts were only established within subclusters (Warren et al.
1996).
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Application of the polymerase chain reaction to typing
A significant disadvantage of typing methods based on RFLP analysis is that a
relatively large quantity (approximately 0.5 to 1.0 Ilg per strain) of high quality DNA
is required. Subculture of M. tuberculosis may take several weeks to generate
sufficient cells for DNA extraction. While this delay may be acceptable for a
retrospective epidemiological study, assuming that stored strains are viable, it is
undesirable where investigation of a continuing outbreak is concerned, particularly if
multidrug resistant strains are involved. The RFLP procedure itself entails DNA
extraction, restriction endonuclease digestion, electrophoresis and Southern blot
hybridisation, and is labour intensive. Several methods based on a polymerase chain
reaction (PCR) to amplify small quantities of DNA have been described, which are
rapid and require only small numbers of cells.
Ross and Dwyer (1993) developed a PCR typing method for M. tuberculosis using
oligonucleotide primers to the ends of the IS6110 insertion sequence in order to
amplify DNA between copies of this element on the chromosome. They were able to
group together strains isolated from epidemiologically related patients with
tuberculosis and to distinguish strains from different clusters of cases, but variations in
some of the minor PCR products occurred which makes the method less suitable for
comparison of large numbers of isolates. A modification of the method, using only
one primer, has been used as a screening method for rapid differentiation of clinical
M. tuberculosis isolates directly from BACTEC broth cultures (Otal et al. 1997).
Results were consistent with those of the standardised RFLP method although the
degree of discrimination was lower.
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An alternative method, termed mixed-linker peR (Haas et al. 1993), amplifies
fragments of DNA between 156110 insertion sequences and linkers ligated into Hha I
restricted genomic DNA at the ends of restriction fragments. This method was used
in the investigation of an outbreak of tuberculosis in a renal unit and gave results very
similar to those of conventional 156110 RFLP analysis (Jereb et al. 1993). However,
careful optimisation of the intermolecular ligation step is required to achieve
reproducibility of this complex procedure (Patel et al. 1996). A modification of the
method with fluorescent detection of PCR products enables DNA fingerprinting
analysis to be automated (Butler et al. 1996). A slightly different strategy, termed
heminested inverse PCR, involves the digestion of mycobacterial DNA with Bse FI,
circularisation of the resulting restriction fragments, then two sequential polymerase
chain reactions which amplify the 5' end of 156110 together with its upstream flanking
sequence (Patel et al. 1996). The method is claimed to be suitable for rapid
fingerprinting of M. tuberculosis strains in epidemiological studies because it requires
much less DNA than conventional RFLP analysis, but has an equivalent
discriminatory power and is technically simple and reproducible. However, although
heminested inverse PCR may be more discriminating than standard RFLP analysis for
strains carrying single copies of 156110, it suffers from a progressive reduction in
clarity of banding patterns with increasing 156110 copy number (Patel et al. 1996).
Other repetitive elements in M. tuberculosis have been investigated as potential targets
for peR-based typing methods. Double repetitive element peR, involving
amplification of DNA segments located between 156110 and the polymorphic GC-rich
repetitive sequence (Friedman et al. 1995), has a discriminatory power similar to that
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of IS6110 RFLP analysis, and uses a boiled suspension of bacterial cells as DNA
source. It may be suitable as a rapid screening method in epidemiological
investigations to subdivide a large number of isolates into clusters for further typing
by RFLP analysis. An alternative method, which can generate reliable patterns
directly from sputum specimens as well as from cultures, uses a PCR and
hybridisation procedure to measure the variability among strains of the distances
between IS6110 elements and copies of the major polymorphic tandem repeat
sequence (Plikaytis et ai. 1993). Another approach is a PCR-based fingerprinting
method using the (GTG)5 oligonucleotide as a primer in association with an IS6110
primer. This was found to be more discriminating than traditional IS6110 typing in a
study of isolates from different regions of Italy and Pakistan (Sechi et ai. 1996).
Each of these techniques uses at least one primer derived from the structure of
IS6110, so that the pattern of the PCR products obtained is not independent of the
number and distribution of IS6110 copies in the genome. Two typing methods exploit
the DNA polymorphism in the spacers found at the direct repeat region of the
chromosome in M. tuberculosis complex strains. Direct variable repeat PCR gives the
sequence of the spacer residues between each 36 base pair direct repeat according to
the first residue at the 5' end of each spacer (Groenen et ai. 1993). 'Spoligotyping'
amplifies the spacers present in a strain by PCR using primers which anneal at each
end of the direct repeat, then detects the presence or absence of spacers of known
sequence by hybridisation of the biotin-labelled PCR product to known spacer
oligonucleotides immobilised on a membrane (Kamerbeek et al. 1994).
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Two technical problems with the use of PCR for fingerprinting have been raised
(Saunders & Ridley 1994). Amplification of large template molecules is less efficient
than that of small fragments and some may not be reliably detected. Methods based
on amplification of DNA between adjacent copies of IS6110 (Ross & Dwyer 1993), or
between IS6110 and another repetitive element (Plikaytis et al. 1993) depend on the
repetitive elements (and hence priming sites) being close enough together for efficient
PCR. In practice, few amplicons are often produced, limiting the discriminative
power of the methods (Patel et al. 1996). Secondly, partial hybrid structures may be
produced in the later cycles of PCR when multiple templates with limited sequence
homology are amplified together, which may appear as artefacts. Further work to
assess the reproducibility and discriminatory power of these techniques is therefore
required.
Random amplified polymorphic DNA analysis (RAPD) is a variant of the polymerase
chain reaction which has been used successfully to type a wide variety of
microorganisms. It does not require genetic knowledge of the target organism but
instead uses a single arbitrary primer which binds to low stringency priming sites on
both strands of DNA close enough together for PCR amplification to occur (Matthews
1993). This method has been applied to M. tuberculosis and was found to be a rapid
and simple alternative to RFLP analysis (Linton et al. 1994). However, many
primers had to be tested before optimal results were obtained, and inconsistency of the
banding pattern between experiments is a particular problem with RAPD. A modified
method has been reported (Abed et al. 1995) in which PCR products obtained by
amplifying the region between 16S and 23S ribosomal RNA genes are used as target
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DNA for RAPD. This generates patterns which are easier to read and have greater
discriminatory power compared to use of whole genomic DNA as RAPD template.
Reproducibility of these methods between laboratories remains to be established
however.
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1.3 MYCOBACTERIUM AVIUM COMPLEX
1.3.1 Infections caused by M. avium complex
M. avium complex (MAC) is increasingly recognised as an important opportunistic
pathogen in patients with AIDS. This organism is an uncommon cause of chronic
pulmonary infection in adults, usually those with pre-existing lung disease (Wolinsky
1979), and in children primary infection may result in cervical lymphadenitis
(Wolinsky 1995). Disseminated infection is virtually confined to patients with very
low CD4 lymphocyte counts « 100 per jLI) as a result of HIV infection (Ellner et al.
1991, Benson & Ellner 1993, Inderlied et al. 1993, Falkinham 1994). Up to 53 % of
AIDS patients in the United States on whom autopsies are carried out have evidence
of disseminated MAC infection (Hawkins et al. 1986), making it one of the most
frequent infective complications of AIDS in the Western world. Of over 12 000 cases
of disseminated non-tuberculous mycobacterial infection in AIDS patients reported to
the Centers for Disease Control, Atlanta by December 1990, over 96% were due to
MAC (Horsburgh 1991). This infection is also frequently seen in AIDS patients in
Europe and Australia, although it appears to be uncommon in Africa (Benson &
Ellner 1993, Pozniak et al. 1996). In the West, the incidence of disseminated MAC
infection has increased in recent years (Nassos et ai. 1991, Yates et ai. 1993). This
may be due to the increasing number of HIV patients who survive to reach very low
CD4 counts as a result of anti-retroviral drug therapy and effective prophylaxis and
treatment of other opportunistic infections. The increase may also partly reflect a
greater enthusiasm by clinicians to seek and confirm MAC infection as its contribution
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to morbidity and mortality in AIDS is more widely acknowledged (Jacobson et ale
1991, Chin et ale 1994c), and as simple blood culture techniques for diagnosis and
relatively non-toxic antimicrobials for treatment are available (Ellner et ai. 1991.
Benson & Ellner 1993).
1.3.2 Microbiology of the M. avium complex
Organisms of the M. avium complex are slow-growing acid fast bacilli which are
usually non-pigmented although some strains may produce a yellow pigment in the
absence of light (Inderlied et ale 1993). They belong to the species M. avium and
M. intracellulare; M. scrofulaceum is related but no longer included in the complex.
Recently, M. celatum, which closely resembles M. avium, has also been recognised as
a cause of disseminated infection in AIDS patients (Piersimoni et ale 1994). On the
basis of phenotypic properties and nucleic acid studies three subspecies of M. avium
have been proposed: M. avium subsp. avium, M. avium subsp. paratuberculosis and
M. avium subsp. silvaticum (Thorel et ale 1990). Members of the group may be
distinguished by serological specificities conferred by oligosaccharide residues of the
C-mycoside glycopeptidolipids which are integral constituents of the cell wall and
envelope. 28 serovars are known, but the ones most often responsible for
disseminated infection in AIDS patients are serovars 1, 4 and 8, all belonging to M.
aviunl (Inderlied et al. 1993).
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1.3.3 Environmental sources and pathogenesis
To date, there has been no evidence of person to person spread of MAC, and the
source of infection in most cases is presumed to be the environment. MAC is widely
distributed and has been isolated from soil, bird faeces, food, cigarettes, natural water
sources and domestic and hospital piped water supplies (du Moulin et al. 1988, Eaton
et al. 1995, Peters et al. 1995, Yajko et al. 1995, Pozniak et al. 1996). The
frequency with which it is isolated from soil samples varies from one geographical
area to another, but does not necessarily correlate with the frequency of disease due to
MAC in the same areas. For example, disseminated MAC infection is more common
in the north-east than in the south-east United States, although the likelihood of
isolating MAC from the environment shows the opposite trend (Falkinham et al.
1980). Likewise, in African AIDS patients disseminated MAC infection is rare,
although high numbers of MAC have been recovered from soil and water samples in
Zaire, Uganda and Kenya (von Reyn et al. 1993b). A study of the home environment
of AIDS patients in California (Yajko et al. 1995) suggested that the soil of potted
plants rather than water or food may be a significant reservoir of M. avium complex.
However, potted plants are usually watered with tapwater and the potting compost is
likely to be more favourable to the survival and multiplication of MAC than treated
piped water, so this finding does not exclude water as the original source of MAC.
The pathogenesis of disseminated MAC infection has not been definitely established,
but it is likely that in most cases recent acquisition of the organism rather than
reactivation of latent infection occurs and that the portal of entry to the body is
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usually the gastrointesinal tract or the respiratory tract. This is supported by
observations that skin test reactivity against M. avium antigens is infrequent amongst
healthy individuals (von Reyn et al. 1993a), and that in some AIDS patients
gastrointestinal or respiratory colonisation may be detected before the onset of
disseminated disease (Damsker & Bottone 1985, Hellyer et al. 1993, Chin et al.
1994a, Havlik et al. 1994). Thus in a prospective study of HIV patients with CD4
counts of < 50 cells/ill the risk of MAC bacteraemia within one year was 60 % for
patients with colonisation of either respiratory or gastrointestinal tract and was greater
than for those without MAC in these sites (Chin et al. 1994a). Of these two sites the
gut may more often be the portal of entry of MAC: it is more often isolated from the
gut than the respiratory tract in HIV patients, and the frequency of gastrointestinal
colonisation increases with the progression of HIV disease (Havlik et al. 1994).
Recently, a cluster of cases associated with a hospital water supply provides further
support to the hypothesis that disseminated MAC infection follows recent acquisition
of the organism (von Reyn et at. 1994). Aerosols generated from natural water
sources have been found to concentrate MAC (Wendt et al. 1980) and may consist of
droplets sufficiently small to reach the alveoli, but whether inhalation of such aerosols
or ingestion of the water is more often the route of MAC colonisation is unknown.
However, in a case-control study of possible environmental risk factors for acquisition
of MAC daily showering, a procedure expected to generate aerosols from the hot
water supply, was actually shown to be protective (Horsburgh et al. 1994). The same
study also found that consumption of hard cheese was a risk factor for disseminated
disease but the association may have been spurious; MAC was not isolated from
cultures of cheese (Yajko et al. 1995, Horsburgh et al. 1994).
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Although colonisation of the gastrointestinal or respiratory tract may precede
disseminated infection with MAC in many cases, prospective studies have shown that
it is not always possible to detect the colonisation stage by means of routine cultures.
and conversely, some patients with positive cultures do not progress to dissemination.
so such surveillance has limited predictive value for disseminated disease (Havlik et
al. 1994). The latter occurs virtually exclusively in patients with severely depressed
CD4 cell counts; the risk of MAC bacteraemia rises progressively as the CD4 count
falls (Nightingale et ai. 1992). Persistent bacteraemia and heavy tissue loads of
organisms, up to 109 to 1010 colony forming units per gram may be found (Wong et
ai. 1985). Organisms are present predominantly in the mesenteric lymph nodes and
Peyer's patches of the gastrointestinal tract and in the liver, spleen and bone marrow,
although almost any organ may be found to be involved at autopsy. They are usually
present within macrophages, with little evidence of granuloma formation or
inflammatory response (Bermudez et ai. 1992, Benson & Ellner 1993, Chin 1993).
Phagocytosis of MAC by macrophages appears to be unimpaired, but intracellular
killing of the organisms does not occur. Production and release of cytokines including
tumour necrosis factor and GM-CSF is reduced in MAC-infected macrophages. Not
all patients who have MAC cultured from blood have unremitting bacteraemia: In a
small proportion bacteraemia is transient, becoming undetectable in the absence of
antimycobacterial therapy. Symptoms are generally fewer and survival longer in this
group (Kemper et ai. 1994).
48
1.3.4 Virulence factors
Characteristics of MAC strains that correlate with virulence have been sought. Strains
isolated from AIDS patients multiply more rapidly in the beige mouse model of
disseminated MAC infection than strains isolated from the environment. Such strains
form mostly smooth flat transparent colonies on Middlebrook 7H 11 agar, compared to
environmental strains which more often give rise to smooth domed opaque colonies
(Reddy et al. 1994). Colonial morphology, while not necessarily a fixed property for
an individual strain, may be relevant because it is thought to be related to the
glycopeptidolipid component of the mycobacterial cell wall. Electron microscopy of
infected macrophages shows phagocytosed organisms surrounded by a multilamellar
electron-translucent zone which resembles glycopeptidolipid. It has been suggested
that this zone may form a barrier which prevents intracellular killing of the organisms
(Shiratsuchi et al. 1994). Possession of plasmids has also been correlated with
virulence in the beige mouse model (Gangadharam et al. 1988) and plasmids have
been found in strains isolated from AIDS patients with disseminated MAC disease
(Crawford & Bates 1986). However, there is considerable heterogeneity in size of the
plasmids identified, and the nature of the gene or genes present on plasmids relevant
to virulence is unknown. Strains of M. avium containing the insertion sequence IS901
have been found to be more virulent in BALBIc mice than related strains lacking
IS901 (Kunze et al. 1991), but this insertion sequence appears to be absent in isolates
fronl AIDS patients.
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1.3.5 Clinical features of disseminated M. aViUlll complex infection
It is not clear why some patients suffer debilitating symptoms from the onset of
disseminated MAC infection whereas others have persistent bacteraemia and appear to
remain asymptomatic. Differences in virulence between strains, or in the immune
response to the infecting organism by different patients may be responsible. The most
commonly reported symptoms of disseminated MAC infection are low-grade fever,
sweats, anorexia, weight loss and malaise. Abdominal pain and diarrhoea are also
sometimes present, and less often hepatosplenomegaly and lymphadenopathy
(Bermudez et ai. 1992, Havlik et ai. 1992, Chin 1993). These symptoms and signs
are not specific to this condition and may also be found in other opportunistic
infections characteristic of AIDS. The laboratory abnormalities most often identified
in patients with disseminated MAC infection are anaemia and elevated serum alkaline
phosphatase levels (Havlik et ai. 1992). A model has been proposed for predicting
MAC bacteraemia in patients with chronic fever and CD4 cell counts of < 50/iLl (Chin
et ai. 1994b).
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1.3.6 Typing methods for M. avium ,complex
As with M. tuberculosis, a discriminative typing system which is able to distinguish
between different strains of MAC would further understanding of the epidemiology of
infections caused by this organism. In particular, a suitable system may be used to
investigate the sources and modes of transmission of MAC, to confirm that most cases
follow recent acquisition of the organism rather than reactivation of latent infection,
and to gain evidence for possible outbreaks of MAC infection among susceptible
individuals.
Methods based on phenotype
Serotyping has been used to investigate MAC strains isolated from human sources,
including patients with AIDS, and from the environment (Tsang et al. 1992). In
general however only a limited number of serotypes, predominantly 4, 8 and 1 have
been found in AIDS patients, and this typing method is not discriminating enough to
be useful. Thin layer chromatography also separates strains on the basis of their
glycolipid content and has been used to investigate false positive MAC cultures arising
from carry-over contamination with a BACTEC system (Bignardi et al. 1994). Other
phenotypic methods investigated for possible use in typing are multi-locus enzyme
electrophoresis (Wasem et al. 1991) and susceptibility to mycobacteriophages.
However, these methods also suffer the drawbacks of limited discriminatory power or
inability to type all strains.
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Restriction fragment length polymorphisln analysis
Methods based on analysis of genotype are more likely to overcome these problen1s.
One approach is RFLP analysis using a probe to an insertion sequence of appropriate
mobility and copy number, as described above for M. tuberculosis. A number of
insertion sequences have been identified so far in the M. avium complex. 15900 is
present in M. paratuberculosis, while the related IS901 and IS902 are found in M.
avium. Possession of IS901 has been used to subdivide M. avium strains into type A,
which lack IS901 and are the predominant type in AIDS patients, and type All which
have multiple copies (McFadden et al. 1992). All strains have been shown to be
more virulent in BALB/c mice in limited studies (Kunze et al. 1991). Plasmid
pMB22 contains a single copy of IS900 and was identified in a genomic library
constructed from a strain of M. paratuberculosis originally isolated from a patient
with Crohn's disease (McFadden et aI. 1987). RFLP analysis of MAC strains using
the restriction endonuclease Pvu II and probe pMB22 suggested that only a limited
number of RFLP types exist and that one particular type predominates in strains
isolated from AIDS patients (Hampson et al. 1989, Visuvanathan et al. 1992).
However, these results are contradicted by more recent work using probes to another
insertion sequence IS1245, and by studies involving separation of large restriction
fragments by pulsed-field gel electrophoresis, discussed below. These suggest that
there is a high degree of polymorphism of strains isolated from different patients. It
is likely that IS900 has a very low degree of mobility, which is responsible for the
appearance of a conserved strain of MAC in AIDS patients, and which restricts its use
as a probe in epidemiological studies.
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By contrast, insertion sequence IS1245 appears promising for use in such work. This
insertion sequence of 1313 base pairs belongs to the same family as IS1081 in
M. bovis and is present in high copy number in the M. avium group but not in
M. intracellulare (Guerrero et ai. 1995). When used for RFLP analysis, human
isolates contained a median of 16 copies of IS1245 and gave a diversity of patterns
comparable to that obtained with pulsed-field gel electrophoresis (PFGE) (Guerrero et
ai. 1995). In some cases isolates sharing indistinguishable PFGE patterns differed in
the position of some of their IS1245 copies. This may reflect superior discriminative
power of IS1245 RFLP analysis compared to PFGE. Alternatively it may mean that
the stability of the insertion sequence is limited, which would be a disadvantage in
epidemiological work.
Two other insertion sequences evaluated in M. avium are ISIII0, a highly mobile
genetic element (Hernandez Perez et ai. 1994), and IS1311, which shows 85 % DNA
homology with IS1245 (Roiz et ai. 1995). When compared to IS900 as a probe for
RFLP analysis, IS1311 gave banding patterns with all of 75 clinical isolates of M.
avium, whereas fewer than 25 % of isolates yielded RFLP patterns with IS900.
Strains from patients with AIDS displayed marked polymorphism (Roiz et al. 1995).
A rapid method for typing isolates of MAC by the polymerase chain reaction has been
described recently (Picardeau & Vincent 1996). This is based on amplification of
genomic sequences located between insertion sequences IS1245 and IS1311 and
appears to be able to discriminate between strains to the same extent as 151245 RFLP
analysis. Although further evaluation is required, the method, which only requires a
crude bacterial lysate as DNA template, is easier to perform than RFLP analysis or
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PFGE and may be useful for the initial examination of large numbers of strains in
epidemiological studies.
Separation of large restriction fragments by pulsed-field gel electrophoresis
An alternative approach to the determination of strain relatedness in MAC is the
analysis of large restriction fragments using pulsed-field gel electrophoresis (PFGE).
Chromosomal DNA analysis using conventional restriction endonucleases has not been
successful because the many restriction fragments produced result in extremely
complex patterns (Wards et ai. 1987). These can be simplified by employing
restriction endonucleases which cut the chromosomal DNA infr,equently, usually at
fewer than 10 recognition sites per 106 base pairs, giving rise to a small number of
large restriction fragments. Mycobacteria are known to have a high proportion (62 -
70 mol %) of guanine plus cytosine in their genomic DNA, so that restriction enzymes
which have 6-base recognition sites rich in adenine and thymine are likely to cut the
genomic DNA suitably infrequently. To prevent cleavage of chromosomal DNA and
large restriction fragments by shearing stresses, bacterial cells are embedded in
agarose before enzymatic treatment to lyse the cell walls and allow penetration of the
restriction endonuclease. Large restriction fragments up to two megabases in size are
then separated by PFGE, in which a homogeneous electric field through the gel
alternates between two orientations 1200 apart throughout the electrophoresis run (Chu
et ai. 1986). Conventional electrophoresis is unable to separate fragments of this size.
Migration of fragments in the gel depends on the potential difference across the gel,
the agarose concentration and buffer composition, the switch time between changes in
angle of the electric field, and the size of the DNA fragments. Large fragments move
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proportionately more slowly than small ones partly because it takes longer for them to
reorientate themselves with respect to the changing electric field. The switch times
selected for each electrophoretic run may be chosen for optimum resolution of DNA
fragments in a particular range of molecular sizes. This technique has been used for a
wide range of Gram positive and Gram negative bacteria and for mycobacteria
including M. tuberculosis (Zhang et ale 1992, Olson et ale 1994), M. bovis (Feizabadi
1996), M. bovis BeG (Zhang et ale 1995), M. fortuitum (Hector et ale 1992) and M.
haemophilum (Yakrus et ale 1994). Compared to RFLP analysis PFGE has the
advantage that a labelled probe, such as to an insertion sequence, is not required, and
therefore the method may in theory be applied to any species without detailed
knowledge of its genomic DNA.
PFGE and field inversion gel electrophoresis, a precursor of PFGE, have been used to
study the taxonomic relationships of the M. avium complex. Wood pigeon
mycobacteria form a homogeneous group that is distict from M. paratuberculosis; M.
avium and M. intracellulare strains may be distinguished (Levy-Frebault et al. 1989,
Coffin et al. 1992). Mazurek et ale (1993) studied large restriction fragment (LRF)
patterns of 35 randomly selected clinical isolates of MAC. The restriction
endonucleases Asn I and Xba I gave clear patterns more consistently than other
enzymes tested. The patterns for unrelated strains were highly polymorphic and each
strain had a unique pattern which appeared to be stable. These properties indicate the
suitability of the method for epidemiological studies of MAC infection. It was also
shown that multiple isolates recovered from the same patient from different sites
andlor over an extended period gave indistinguishable LRF patterns. These
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observations were confirmed and extended by Arbeit et al. (1993), who isolated At.
avium from prospective cultures on 14 HIV-infected patients. Although serotyping
and ribotyping were of limited use in discriminating between isolates from different
patients, LRF patterns produced by Ase I (analogous to Asn I) and resolved with
PFGE showed that each patient was infected with a unique strain. Such genetic
diversity supports the hypothesis that MAC infection in AIDS patients is usually
acquired from a variety of environmental sources. Furthermore, of 13 patients with
MAC bacteraemia two patients had concurrent infection with two distinct strains.
Subsequent work showed that 4 out of 12 patients from whom sequential cultures were
collected within a two week period had two distinct MAC strains, which was
suggested to reflect ongoing polyclonal infection (Slutsky et al. 1994). This
observation is relevant when multiple strains in a single patient differ in antimicrobial
susceptibility, as demonstrated for four out of five patients with polyclonal M. avium
infection (von Reyn et al. 1995). Treatment directed at one strain could result in
selection of the other resistant strain under these circumstances.
PFGE was used in a prospective study which identified hospital hot water supplies as
a source of M. avium infection in AIDS patients (von Reyn et al. 1994). 81 % of 36
patients examined were infected with their own unique strain of M. avium, but three
clusters of two or three patients with indistinguishable strains were also found. For
two of the clusters the same strain was also isolated repeatedly from the recirculating
hot water system of the hospitals attended by the patients, who had no other common
exposures.
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1.4 SCOPE OF THE STUDY
M. tuberculosis
The epidemiology of mycobacterial disease in patients infected with HIV has been
well documented in some countries, especially the United States. However, much less
was known about the United Kingdom situation at the commencement of this study
(1993). With regard to M. tuberculosis, there are several questions to be addressed.
To what extent has HIV co-infection contributed to the increase in notifications of
tuberculosis in Britain in recent years? Is there evidence for outbreaks of tuberculosis
among patients in HIV units as observed elsewhere, and are these patients more likely
to be infected with drug resistant strains? Studies abroad have suggested that the
proportion of cases of active tuberculosis due to recently acquired infection rather than
reactivation of old disease is higher than expected. Does the same apply to HIV
patients in the United Kingdom? While conventional epidemiological methods may
help to answer some of these points, the application of molecular biological
techniques, especially RFLP analysis to a suitable sample of strains is needed to
resolve these issues.
M. aviull1 complex
The epidemiology and pathogenesis of disseminated MAC infection are less clearly
established than for tuberculosis. In particular, the degree of heterogeneity among
strains causing disseminated infection in HIV patients in the United Kingdom is
unknown. The portal of entry of the organism is often unclear, but might be inferred
in some cases if strains causing disseminated infection were found to be similar to
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those isolated from superficial sites such as the gastrointestinal or respiratory tracts.
It is unknown whether patients with persistent MAC infection over a period of time
have the same strain throughout or a sequence of infections with different strains.
Most cases are assumed to arise from sporadic infection in a susceptible individual
from an environmental source, but the occurrence of common source outbreaks in
HIV units has not been sought in Britain, although there is evidence that small
outbreaks have occasionally happened in the United States. Again, these questions
can be investigated further by applying a discriminative typing method to an
appropriate sample of stains.
Location of the study
The Communicable Disease Surveillance Centre (CDSC) of the Public Health
Laboratory Service (PHLS) has a voluntary confidential reporting system for cases of
HIV infection and AIDS. So far, more cases have been reported from the Thames
regions than from any other part of the United Kingdom: 16253 persons infected with
HIV out of a total of 25276 up to the end of September 1995 (CDSC 1995a), and
8281 AIDS cases out of 11872 between January 1982 and December 1995 (CDSC
1996b) . Data from unlinked anonymous HIV testing among patients attending
genitourinary medicine clinics and women giving birth also confirm that the
prevalence of HIV-1 infection is much higher (range 4.0 to 19.1 times) in London and
the South East than elsewhere in England and Wales (CDSC 1996c). Most of the
microbiology departments serving hospitals in the South East (roughly, the area east
of Oxford and South of Cambridge and including Greater London), including all but
one of the laboratories associated with the HIV units in London, send mycobacteria
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isolated from clinical specimens to the Mycobacterium Reference Unit at Dulwich
Public Health Laboratory for identification and susceptibility testing (Figure 1. 4-.1).
Isolates from persons identified as HIV positive by the referring laboratory have been
stored since the early 1980s. This collection of stored strains, which is likely to be
the most extensive and representative collection of mycobacteria isolated from HIV
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South East England, showing the location of laboratories which submitted isolates of
mycobacteria to Dulwich Public Health Laboratory for identification and susceptibility
testing in 1994. In addition to those shown, isolates were also received from 31




This study used cultures of M. tuberculosis isolated from known HIV seropositive
patients and referred by laboratories in South East England to the Regional
Tuberculosis Centre at Dulwich Public Health Laboratory between January 1991 and
June 1994. As they were received, the identification of the isolates was confirmed
and their susceptibility to first line antituberculous drugs determined, as part of the
routine work of the reference laboratory. The isolates were then stored on 2 ml
Lowenstein-Jensen slopes at room temperature until required. All work on live
cultures of M. tuberculosis was performed in a Class 1 safety cabinet within Category
3 accommodation.
2.1.1 Identification of M. tuberculosis
For each culture, a film was prepared and stained by the Ziehl-Neelsen method to
confirm the presence of acid-fast bacilli. A smooth suspension of cells was then
obtained by stirring a 10 J-tl loopful of culture into 1 m! phosphate-buffered saline with
large glass beads on a magnetic stirrer for several minutes. This suspension was used
to inoculate three Lowenstein-Jensen slopes: one was incubated at 25°C, one at 37°C
and exposed to light, the third contained 500 mg/l p-nitro benzoic acid (PNBA) and
was also incubated at 37°C. In these screening tests members of the M. tuberculosis
complex do not grow at 25°C, do not produce pigment, are inhibited by PNBA. and
visible growth is not apparent within three days. The subspecies of the
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M. tuberculosis complex (M. t. tuberculosis, ajricanum, bovis, BeG) may be
distinguished by a further battery of tests (Collins et al. 1985). These include
preference for aerobic or microaerophilic growth, preference for growth on
Lowenstein-Jensen slopes containing pyruvate or glycerol, susceptibility to 5 mgll
thiophen-2-carboxylic acid hydrazide (TCH), 25 mgll cycloserine, and 66 mg/l
pyrazinamide (PZA), and ability to reduce nitrate to nitrite (Table 2.1). Only isolates
of M. tuberculosis were investigated in this study.
Table 2.1.1 Identification of M. tuberculosis subspecies
I I
Subspecies Oxygen Pyruvate: TCH Cyclo- PZA Nitrate
Glycerol I reductionpreference senne
Classical A P=G R S S +
I I I
South A P=G S S S +,
I iIndian
I
I African I M P>G S i S S -
i I
African II M P>G S S S +
I
I Bovis M P>G S S R -
I
BCG A G>P S R R V
II
A aerobic, M microaerophilic, R most strains resistant, S most strains
susceptible, + positive reaction, - negative reaction, v variable
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2.1.2 Susceptibility testing
The susceptibility of isolates to streptomycin, isoniazid, ethambutol and rifampicin
was determined by the resistance ratio method (Collins et ai. 1985).
A series of Lowenstein-Jensen slopes containing doubling dilutions of each drug to be
tested was prepared. The final drug concentrations used were as follows:
streptomycin 40 to 2.5 mgll, isoniazid 0.2 to 0.125 mgll, ethambutol 3.2 to 0.2 mg/I,
and rifampicin 50 to 3.125 mg/I. 5 III of the bacterial suspension prepared above
was inoculated onto each tube and onto one drug-free slope. Control strains of M.
tuberculosis of known susceptibility were also tested. The slopes were incubated at
37°C and read after 10 days, or a further 7 days if growth on the drug-free slope was
initially poor. The slope containing the lowest concentration of drug to yield fewer
than 20 colonies of the test strain after this time was taken as the end-point. Strains
were regarded as sensitive to the drug if the ratio of the minimum inhibitory
concentration (MIC) of the test strain to the MIC of the control strain was 2 or less,
and resistant if the ratio of the MICs was 4 or more.
Susceptibility to pyrazinamide was tested in a mixed solid/semi-solid medium at acid
pH. Tubes containing 1 ml of Lowenstein-Jensen medium, pH 5.2 with 66 mgll
pyrazinamide were prepared, and layered with 2 ml of semi-solid Kirchner medium
containing 8 % oleic acid-albumin-dextrose-catalase (OADC) enrichment (Becton-
Dickinson), 3 gil sodium pyruvate, 1 gil agar and 66 mg/l pyrazinamide, pH 5.2.
Similar tubes without pyrazinamide were also made up. One pair of tubes was
inoculated with 20 III of bacterial suspension and one pair with 20111 of a 1 in 10
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dilution of the suspension. The test strain was reported as susceptible to pyrazinamide
if growth occurred in the control tube but not in the drug-containing tube with either
the original or the diluted suspension.
2.1.3 Subculture of stored strains
From June 1993 onwards each stored strain was subcultured onto a 5 ml Lowenstein-
Jensen slope as well as in 2 ml Middlebrook 7H9 broth (Difco) containing 10%
OADC supplement. If no growth was visible on the slope after 6 weeks incubation at
37°C, the broth cultures were subcultured to further Lowenstein-Jensen slopes.
Strains were considered to be non-viable if no growth was apparent after 12 weeks
incubation. Slopes yielding sufficient growth were harvested using a cotton swab
moistened in sterile distilled water to pick up as many colonies as possible. These
were dispersed by agitating the swab in 0.6 ml Tris EDTA (TE) buffer (10 mM Tris,
1 mM EDTA, pH 8.0) in a labelled microcentrifuge tube.
2.1.4 Restriction fragment length polymorphism analysis
The method used for RFLP analysis of M. tuberculosis is based on that of van
Soolingen et al. (1993b) with modifications, and conforms with the recommendations
for a standardised methodology for this procedure proposed by an international group
(van En1bden et al. 1993).
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Preparation of chromosomal DNA
The harvested cells were killed by heating the microcentrifuge tubes in a water bath at
80°C for at least 20 minutes. When cool, the cell walls were lysed by incubating with
lysozyme (Boehringer Mannheim, 1 mg/ml final concentration) for 90 minutes at 37°C
followed by proteinase K (Boehringer Mannheim, 0.2 mg/ml) and 1% sodium dodecyl
sulphate (Sigma) for 30 minutes at 65°C. Cell wall debris, denatured protein and
polysaccharide were then removed by complexing with cetyl-dimethyl ethyl
ammonium bromide (Sigma, 10 mg/ml) in the presence of sodium chloride, followed
by extraction with chloroform: isoamyl alcohol (24: 1). After centrifugation, the
upper layer of aqueous supernatant was pipetted to a fresh tube and the DNA
precipitated with an equal volume of isopropanol at -2ifC. The precipitate was
washed in cold 70 % ethanol then redissolved in 20 iiI TE buffer and stored at 4°C.
Restriction digestion of chromosomal DNA
10 iiI of each DNA preparation was digested with 10 units of restriction endonuclease
Pvu II (Gibco), using the restriction buffer provided with the enzyme. The incubation
was carried out for 4 hours at 37°C in a total volume of 20 iLl, then the reaction was
stopped by adding 5 iLl of loading buffer (30% glycerol, 0.15% bromophenol blue,
EDTA) containing internal size markers.
To assess the concentration of DNA in the samples and to check digestion 5 iLl of
each preparation was applied to the slots of a 0.8 % agarose gel in TAE buffer (40
111M Tris, 20 mM acetic acid, 1 mM EDTA) containing O.S mg/l ethidium bromide.
1 iLg of lambda phage DNA digested with Hind III (Gibco BRL) was also applied to
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the gel as a molecular weight marker. Electrophoresis was carried out at 80V for one
hour before taking a Polaroid photograph of the gel on an ultraviolet transilluminator.
From this photograph the volume of each preparation containing 1 /Lg DNA for
Southern blotting was estimated.
Electrophoresis and Southern transfer of the DNA restriction fragments
Electrophoresis of the fragments was carried out in a 20 x 20 cm 0.8 % agarose (DNA
grade, Biorad) gel containing 0.5 mg/l ethidium bromide. The gel was submerged in
TAE buffer and loaded with up to 24 samples, each containing approximately 1 /Lg
DNA, plus molecular weight markers (lambda Hind III fragments end-labelled with
digoxigenin-dUTP (Boehringer Mannheim) using Klenow DNA polymerase) at each
end. The electophoresis was run at 25 volts for approximately 16 hours, until the 2.0
kilobase fragment of the molecular weight marker had migrated 7 em from the wells,
when viewed on an ultraviolet transilluminator. The gel was exposed to ultraviolet
light for 5 minutes then immersed in 0.25 M hydrochloric acid for 20 minutes. These
steps nicked and depurinated the DNA fragments, facilitating their subsequent transfer
by blotting. After rinsing in distilled water the gel was incubated twice for 15
minutes in denaturing solution (0.5 M sodium hydroxide, 1.5 M sodium chloride) to
denature double stranded DNA, then for 30 minutes in neutralising solution (1.5 M
sodium chloride, 1.0 M Tris, pH 7.4) before blotting. For this, the gel was placed on
a sheet of Hybond-N nylon membrane (Amersham International) moistened with 2 x
sse (0.3 M sodium chloride, 0.03 M sodium citrate, pH 7.0) on a Hybaid vacuum
blotter. The gel was covered with 2 x sse and a vacuum applied for 60 minutes to
transfer DNA fragments to the membrane. The DNA was then crosslinked to the
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membrane by exposure to 120 000 pJ/cm2 in an ultraviolet Stratalinker 1800
(Stratagene) before hybridisation.
Preparation of 186110 probe by peR
A probe to IS6110, labelled with digoxigenin, was prepared in a polymerase chain
reaction. The reaction mix contained 5 pJ target DNA (pRP 2001, a plasmid
containing IS6110), 5 pJ each of primers ISTB5 and ISTB6 (a gift of Dr P Godfrey-
Faussett), deoxy-nucleoside triphosphates (2.5 pJ of 2 mM dATP, dCTP and dGTP
plus 3.3 pJ of 1 mM dTTP) , 1.7 pJ digoxigenin-11-dUTP, 2 pJ dimethylsulphoxide, 5
ILl lOx Cetus buffer (500 mM potassium chloride, 15 mM magnesium chloride, 100
mM Tris, pH 8.3) and 0.5 ILl Taq DNA polymerase (5 U/ILI, Boehringer-Mannheim),
made up to 50 ILl with sterile distilled water. The reaction mix was overlaid with
mineral oil then subjected to the following conditions in a thermal cycler: 3 minutes
at 90°C, followed by 30 denaturing/annealing/synthesising cycles of 90°C for 40
seconds/50°C for 40 seconds/72°C for 2 minutes, and finally 10 minutes at 72°C.
At the end of the polymerase chain reaction, the entire reaction mix was loaded onto a
gel of 0.8 % low melting point agarose (Biorad) containing ethidium bromide and
electrophoresis was carried out at 80 volts for one hour. The gel was then viewed on
an ultraviolet transilluminator and the band corresponding to the labelled product was
cut from the gel with a sterile scalpel blade, and weighed in a microcentrifuge tube.
Sufficient sterile distilled water was added to dilute the agarose to 0.2%, which was
then melted by heating at 65°C. The preparation was stored in 100 J.LI aliquots at 4llC.
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To assess the activity of the labelled probe prepared in this way, 10 III of pRP2001
DNA (containing IS6110) was crosslinked to four pieces of Hybond-N membrane
which were sealed into small plastic envelopes each containing 5 ml pre-hybridisation
solution. After incubating for one hour at 65°e different quantities of probe (2. 10,
25 and 50 pJ) which had been boiled and cooled on ice were added to each envelope.
Hybridisation was carried out at 65°e overnight. The membranes were then washed
and digoxigenin detected in a chemiluminescent reaction, as described below. The
optimum concentration of probe was 2 pJ per 5 ml hybridisation solution.
Hybridisation
The crosslinked membrane was moistened with 2 x sse and inserted into a clean
glass hybridisation bottle. 25 ml prehybridisation solution (5 x sse, 0.1 % N-Iauroyl
sarcosine (Sigma), 0.5% sodium dodecyl sulphate, 3% dried skimmed milk (Safeway»
warmed to 65°e and containing 0.5 ml herring sperm DNA solution (5 mg/ml, Sigma)
which had been boiled then cooled on ice, was added to the bottle. Prehybridisation
continued for one hour at 65°e in a rotating hybridisation oven (Hybaid), then 10 III
of digoxigenin-Iabelled probe to IS6110, made single stranded by boiling for 5
minutes then chilling on ice, was added to the bottle. After hybridisation at 65°e
overnight, the hybridisation mix containing probe was removed and the membranes
washed twice in a solution of 2 x sse, 0.1 % sodium dodecyl sulphate, 0.02 % N-
lauroyl sarcosine and once in TBS (0.1 M Tris, 0.15 M sodium chloride, pH 7.5).
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Chemiluminescent detection of 186110 probe
Non-specific protein binding sites on the membrane were blocked by incubating in 25
ml of 3% milk solution (in TBS) for one hour at 37°C. Antibody to digoxigenin
conjugated to alkaline phosphatase (Boehringer-Mannheim, 2.5 ttl in 25 ml of freshly
prepared 3 % milk solution containing 0.5 % Tween 20) was then added and incubated
at 37°C for a further 30 minutes. After washing six times in TBS containing 0.5%
Tween 20 the membrane was equilibrated in alkaline phosphatase reaction buffer (0.1
M sodium chloride, 0.01 M magnesium chloride, 0.1 M Tris, pH 9.5) for five
minutes at room temperature. Lumiphos-540 (Boehringer-Mannheim), a substrate of
alkaline phosphatase which gives out light when converted to product by the enzyme,
was applied to the surface of the membrane which was then sealed into a clear plastic
bag. After preincubation at 37°C for 30 minutes to allow the enzyme reaction rate to
increase, the bag was sealed into an exposure cassette with an X-ray film (Hyperfilm
MP, Amersham International) and reincubated at 37°C. After an exposure of
approximately 90 minutes, the film was removed and developed (Kodak GBX
developer and fixer solutions). A shorter or longer exposure was sometimes required
depending on the intensity of bands on the resulting autophotograph.
Preparation and detection of internal size markers
In order to facilitate comparison between different gels internal molecular weight
nlarkers were included in the tracks of every DNA sample, as recommended by van
Soolingen et ai. (1993). These were prepared from a supercoiled DNA ladder (Gibco
BRL) digested with Pvu II added to PhiX 174-Hae III DNA (Gibco BRL), to give a
ladder of about 15 resolvable bands between 16.2 and 0.6 kilobases in size.
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After the first hybridisation, the membrane was returned to a roller bottle and the
probe to IS6110 removed by incubating twice with 0.4 M sodium hydroxide, 0.1 <7c
sodium dodecyl sulphate at 45°C for 30 minutes, then rinsing twice in 2 x SSC.
Prehybridisation was carried out as above, then a second hybridisation with
digoxigenin-Iabelled probes to the internal size markers continued overnight at 65°C.
These probes (10 ttl of each in 25 ml prehybridisation solution) were pUC9.2 for the
supercoiled DNA fragments and PhiX 174-Hae III fragments, both labelled with
digoxigenin by random priming using T7 DNA polymerase (Gibco BRL), random
nona-nucleotides, and a mixture of unlabelled deoxynucleoside triphosphates plus
digoxigenin-ll-dUTP (Boehringer-Mannheim). Finally, the membrane was washed
and probes from the second hybridisation detected using anti-digoxigenin antibody
conjugated to alkaline phosphatase and Lumiphos-540 chemiluminescent substrate as
described above.
2.1.5 Computer analysis of 186110 restriction fragment length
polymorphism patterns
The autophotographs showing the IS6110 RFLP patterns of the isolates were scanned
using a Hewlett Packard Scanjet 3C scanner and the data loaded into a Compu-Add
CP90P computer set up with Gelcompar for Windows software (Applied Maths
BVBA). After converting each gelscan into Gelcompar format, the patterns were
normalised by aligning the reference positions (lambda Hind III markers) at both ends
of each gelscan with a pre-selected standard reference track. This allowed comparison
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between gelstrips on different gelscans. Although it was originally intended to use the
internal molecular weight markers for normalisation of the gels, use of the lambda
Hind III markers on the same scan was generally satisfactory and considerably simpler
than normalisation with two scans for each gel. Each gelstrip was then inspected to
ensure that the peaks selected by densitometric scanning corresponded with the
position of the bands on the original autophotograph. Two lists of isolates to be
compared, one of isolates from HIV seropositive patients and one of isolates from
controls, were drawn up. The degree of similarity between tracks in each list based
on the position of assigned bands was calculated using the coefficient of Jaccard, and
the tracks were clustered in the form of dendrograms by the unweighted pair group
method using arithmetic averages.
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2.2 MYCOBACTERIUM A VIUM COMPLEX
2.2.1 Selection, identification and storage of isolates
HIV seropositive patients with disseminated M. avium complex (MAC) infection were
identified from the records of isolates referred to the Regional Tuberculosis Centre at
Dulwich Public Health Laboratory between December 1991 and June 1994. Patients
with more than one available isolate, including at least one grown from a blood
culture or bone marrow specimen, were selected.
Isolates were identified as MAC at the time of referral to the laboratory by the
following characteristics: small coccoidal acid fast bacilli on Ziehl-Neelsen stain,
slow growth (> 3 days) at 25°C, 37°C and variably at 44°C, failure to hydrolyse
Tween 80 and to reduce nitrate. They were then stored on small Lowenstein Jensen
slopes at room temperature.
2.2.2 Separation of large restriction fragments by pulsed-field gel electrophoresis
Subculture of isolates
Each isolate was subcultured by inoculating 10 ml of Middlebrook 7H9 broth (Difco)
containing 10% DADC supplement (Becton-Dickinson) and 0.05% Tween 80 and
incubating at 37°C until the late exponential phase of growth, 5 to 10 days. The
cultures were centrifuged at 3000 rpm for 10 minutes, then the pellet was resuspended
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in 200 ~l of TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0) and heated at 8CfC for
30 minutes.
Preparation of agarose plugs and liberation of intact mycobacterial DNA
This was a modification of the method of Mazurek et al. (1993). 50 ILl of cell
suspension was mixed with an equal volume of 2% low melting point agarose (Biorad)
and transferred to a plug mold. When the plug had set it was transferred to a
microcentrifuge tube containing 500 ~l of lysozyme (Boehringer-Mannheim) 1 mg/ml
in TE buffer, and incubated at 37°C for 2 hours. The solution was then aspirated and
replaoed with 500 ~l of TE buffer containing 0.2 mg/ml proteinase K (Boehringer-
Mannheim) and 1% sodium dodecyl sulphate (Sigma) and incubated at 50°C
overnight. The plugs were then washed four times in TE buffer (4 x 1 hour) at room
temperature. 1 mM phenylmethyl sulphonyl fluoride (Sigma), freshly prepared from
stock solution was added to the second wash to neutralise remaining proteinase
activity. Plugs were stored in TE buffer at 4°C until required.
Restriction endonuclease digestion
Half of each plug was incubated in 500 ILl of restriction enzyme buffer (NEB 3 for
Ase I: 100 mM sodium chloride, 50 mM Tris-HCI, 10 mM magnesium chloride, 1
mM dithiothreitol, pH 7.9) in a microcentrifuge tube for one hour at room
temperature. The buffer was then aspirated and replaced with 100 ~l of fresh
restriction enzyme buffer containing 10 units (1 ILl) Ase I (New England Biolabs).
Digestion was carried out at 37°C overnight. Some strains were also digested with 20
units Xba I (New England Biolabs) in NEB 2 buffer (50 mM sodium chloride, 10 mM
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Tris-HCI, 10 mM magnesium chloride, 1 mM dithiothreitol, pH 7.9) under the same
conditions.
Pulsed-field gel electrophoresis
Each plug containing restriction digested DNA was equilibrated in 500 ]LI
electrophoresis buffer (0.5 x TBE: 45 mM Tris, 45 mM borate, 1.0 mM EDTA, pH
8.3) for 30 minutes at room temperature, then transferred to a tooth on a 15 tooth
comb held in a gel casting stand. Agarose plugs containing concatamers of lambda
phage DNA (size range 48.5 to 1018 kilobases, Biorad) were placed on teeth at both
ends of the comb as molecular weight markers. 100 ml of pulsed-field certified
agarose (Biorad, 1 g/100ml in 0.5 x TBE buffer), melted and cooled to 50°C were
poured into the casting stand around the comb and allowed to set. After removing the
comb from the gel the remaining wells were filled with agarose and the gel was
transferred to the electrophoresis tank of a Biorad CHEF-DR II system (Clamped
Homogeneous Electric Fields with Dynamic Regulation) containing two litres of 0.5 x
TBE buffer. PFGE was carried out for 21 hours at 6.0 volts/cm. Switch time
increased linearly from 20 seconds at the start of the run to 60 seconds at the end for
plugs containing DNA digested with Ase I, and from 10 to 50 seconds for plugs
treated with Xba 1. The temperature was maintained at 15°C throughout by
recirculating buffer through a chiller. At the end of electrophoresis the gel was
stained in 0.5 ]Lg/ml ethidium bromide solution for 20 minutes then destained in
distilled water for 2 hours. DNA fragments were visualised by placing the gel on an





Viability of stored strains
Between January 1988 and June 1994 inclusive 269 isolates of mycobacteria from HIV
seropositive patients were referred to the PHLS Regional Tuberculosis Centre at
Dulwich and were confirmed as M. tuberculosis. When these stored isolates were
subcultured (starting in June 1993) their viability was found to be dependent on the
age of the cultures (Table 3.1.1). Overall, 89% of isolates less than a year old at the
time of subculture were viable, whereas 42 % of cultures between one and two years
old, and only 11 % of cultures more than two years old were still alive.
Table 3.1.1 Viability of stored isolates of M. tuberculosis
referred from HIV seropositive patients.
I Year I Number of cultures Number (%) of cultures Ireceived viable on subculturea
1988 13 0 (0)
1989 I 35 4 (11.4)
1990 28 4 (14.3)
1991 39 5 (12.8)
1992 73 51 (69.9)
I 1993 42 37 (88.1)
1994b 39 35 (89.7)
Total 269 136
a commenced June 1993
b January to June
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Numbers of cases and controls
128 of the viable isolates, obtained from 96 HIV patients, were studied further.
Between one and three isolates were referred from each patient. The laboratories
from which these isolates were referred, all in London or South East England, are
listed in Table 3.1.2.
For comparison, 90 further isolates from 84 patients not identified as HIV seropositive
by the referring laboratory were selected as controls. These were received between
February and September 1993 from the same laboratories that had sent isolates from
HIV patients (Table 3.1.2).
69 % of the HIV positive cases were male compared to 59 % of the controls. The age
of the cases at the time that tuberculosis was diagnosed was known for 81 out of 96
HIV patients and for 64 of the 84 controls. The median age at diagnosis was 35 years
for HIV cases (standard error 8. 8 years) and 39 years (standard error 15.7 years) for
the controls.
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Table 3.1.2 Laboratories from wbich the M. tuberculosis
isolates used in this study were referred.
I, , INumber of.1 Referring laboratory Number of HIVI
I positive cases control cases I
,
I
Chelsea and Westminster Hospital* 20 17
University College Hospital 18 31
S1. George's Hospital 7 2
Charing Cross Hospital 5 0
King's College Hospital 5 5
I Royal London Hospital 5 4
, St. Andrew's Hospital 5 I 2
North Middlesex Hospital 4 2
I
Royal Free Hospital 4 7
I Ealing Hospital 3 2
Whipps Cross Hospital 3 1
Central Middlesex Hospital 2 3
Hammersmith Hospital 2 I 2
Institute of Neurology 2 0
I Northwick Park Hospital, Harrow 2 3
Greenwich District Hospital 1 0
Kingston Hosptal 1 0
II
Maidstone Hospital 1 0
Mount Vernon Hospital 1 0
1'1 Royal Sussex County Hospital, Brighton 1 0 II I I
St. Bartholomew's Hospital 1 2
Watford General Hospital 1 0
I West Middlesex Hospital 1 0
1'1 Whittington Hospital 1 0
I
Margate Hospital 0 1
Total 96 I 84
* including Westminster Hospital prior to 1993
79
The likely ethnic origins of HIV positive cases and controls were estimated by
inspection of surnames, as done by Yates et ai. (1993) (Table 3.1.3):
Table 3.1.3 Presumed ethnic origin of HIV positive cases and controls.
Presumed ethnic origin Number (%) of HIV Number (%) of controls
seropositive cases
European 55 (57.3) 51 (60.7) ,
African 33 (34.4) 18 (21.4)
Indian subcontinent 3 (3.1) 15 (17.9)
Other* 5 (5.2) 0
Total 96 84
*includes Oriental and unknown names (for example, STD clinic numbers)
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Sites of infection
The sites of infection from which M. tuberculosis was isolated in the two groups are
shown in Table 3.1.4. Pulmonary infection was the most frequent site in both groups,
although the proportion of cases with pulmonary infection was higher in the control
group. Isolation from blood cultures or bone marrow occured in 16/96 (17 %) HIV
patients but was not found among the control group.
Table 3.1.4 Clinical sites from which M. tuberculosis was
isolated in HIV positive patients and controls.






sputum 35 (36) 47 (57)
bronchoalveolar lavage fluid 14 (14) 7 (8) I
pleural fluid/biopsy I 5 (5) i 8 (10)
Lymph node, neck abscess 22 (23) 10 (12)
Blood culture, bone marrow 16 (16) 0
i Urine 11 (11) 0
I Stool 7 (7) 1 (1)
I Gastric washing 1 (1) 0
iCSF, brain abscess 2 (2) 0
I
Peritoneal fluid/biopsy 2 (2) 4 (5)
I I
Bone, spine 0 4 (5)
I Other (tissue biopsy) 5 (5) I 6 (7)
Some patients had positive cultures from more than one site
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Drug susceptibility
The susceptibility of the isolates to 'first line' antimycobacterial drugs (rifampicin.
isoniazid, ethambutol, pyrazinamide and streptomycin) is shown in Table 3.1.5. The
majority of isolates from both groups were susceptible to all drugs tested. 8/96
(8.3 %) HIV patients and 1/84 (1.1 %) controls had isolates resistant to two or more
antituberculous drugs, but only two cases, both HIV positive patients, had isolates
resistant to both rifampicin and isoniazid.
Table 3.1.5 Susceptibility of M. tuberculosis isolated from HIV patients
and controls to first line antimycobacterial drugs
,I
,ISusceptibility Number of I Number of
, HIV patients controlsI I
Fully susceptible
I (to rifampicin, isoniazid, pyrazinamide, 77 77
" ethambutol and streptomycin) I"
I
Resistant to one drug:
isoniazid 7 3
streptomycin 3 3
pyrazinamide 2 I 0
Resistant to two drugs:
i
isoniazid and streptomycin 4 1
I
isoniazid and rifampicin 2 0
Resistant to three drugs:
isoniazid, streptomycin and ethambutol 2 0
Total 97* 84
*includes one patient with two isolates of different susceptibilities
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RFLP analysis
RFLP patterns were obtained for all 218 isolates that yielded sufficient growth.
Examples of autophotographs are shown in Plates 1 and 2. Each isolate gave at least
one band when hybridised with the digoxigenin-Iabelled probe to 156110, indicating
that all isolates contained at least one copy of this insertion sequence. The majority of
isolates had between 8 and 13 copies (Figure 3.1.1).
HIV seropositive patients
Two or three viable isolates were received in each case from 25 of the patients in this
group. In most of these, isolates were from different clinical sites, forwarded to the
reference laboratory at the same time. In each case, visual inspection of the RFLP
patterns showed that the different isolates were indistinguishable in terms of the
number, position and intensity of the bands. 23 of the 25 cases had similarity
coefficients of 100% for the different isolates when analysed by Gelcompar. In the
other two cases, differences in gel loading or electrophoretic migration between gels
may have accounted for failure of the system to recognise similar patterns as the
same.
Two isolates with different susceptibility patterns were received from one HIV
positive patient. The second isolate, cultured from a sputum specimen and resistant to
pyrazinamide, was referred eight n10nths after the first one, which had been isolated
from a lymph node biopsy and was fully sensitive to antimycobacterial drugs. Both
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Figure 3.1.1
Number of bands
Distribution of bands (IS6110 copies) among M. tuberculosis isolates
from 96 HIV seropositive and 84 control patients with tuberculosis.
84-
M 1 4 7 10 13 16 19
Plate 1
Autophotograph of RFLP patterns obtained for 22 M. tuberculosis isolates from 18
HIV seropositive patients. Pvu II fragments of chromosomal DNA containing IS6110
were detected with a digoxigenin-Iabelled probe to this insertion sequence.
The pairs of isolates in lanes 3/8, 17/18, 19/20, 21/22 were from patients with more
than one positive culture (at diffemt body sites) in each case, and appear
indistinguishable. By contrast, the indistinguishable isolates in lanes 1 and 3/8 and in
lanes 10 and 11 were from different patients, representing clusters of cases (patients
B A and H I in Table 3.1.6).
M: lambda Hind III molecular weight marker (23.1 9.4 6.6 4.4 2.3, 2.0 0.6
kiloba e ).
85
M 1 4 7 10 13 16 19
Plate 2
Internal molecular weight markers, on the same membrane as shown in Plate 1.
The IS6ll0 probe was removed by treatment with sodium hydroxide and SDS, then a
second hybridisation with probes to the internal molecular weight markers applied to
each sample of mycobacterial DNA (Pvu II-digested supercoiled DNA ladder and
Phi X 174-Hae III) was carried out.
M: lambda Hind III (external) molecular weight marker
isolates had the same RFLP pattern. Information on the drug therapy received by this
patient was not available however.
Overall, a high degree of heterogeneity was observed between strains isolated from
different patients (Figure 3.1.2). However, four clusters of cases were observed in
which indistinguishable strains were isolated from between two and five patients.
These are summarised in Table 3.1.6.
Table 3.1.6 Clusters of cases with indistinguishable strains
of M. tuberculosis on RFLP analysis.
Patient Age/Sex Source lab. Positive specimens Date referred
A 23 M UCB Bronchial washing, urine July - August 1992
B 24 F UCB Sputum, pleural fluid, blood Sept. - Oct. 1992
C 42 M UCB Blood November 1992
I
D 41 M Charing Cross Sputum, bronchial washing, urine March 1993
E 24 M UCB Pleural fluid August 1993
F 32 M N. Middlesex Lymph node December 1991
G NS F N. Middlesex Urine March 1992
B 34 M Westminster Lymph node July 1992
I 46 M Royal London Lymph node, sputum July 1992 - March 93
J 30 M Royal London Sputum October 1993 i
K 27 M Westminster Sputum November 1993
L NSM Royal Free Sputum December 1993
NS: not stated
Four clusters of cases were detected:
patients A - E: 10 bands (IS6110 copies)
patients F - G: 14 bands
patients B-1: 8 bands
patients J - L: 12 bands
All isolates were susceptible to rifampicin, isoniazid, pyrazinamide, ethambutol and streptomycin,
except the second isolate from patient I which had acquired resistance to pyrazinamide.
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RFLP analysis was repeated in parallel on strains from patients A to D, and
confirmed the initial findings (Plate 3). Patient E, who belonged to the control group.
was only recognised as part of the same cluster at a later stage.
Further clinical and epidemiological information on patients F to L involved in the
three smaller clusters was not available as these patients had been diagnosed and
treated at genitourinary medicine clinics. However, permission was obtained to
examine the case histories of the patients identified in the first, larger cluster from the
clinicians responsible for their care.
Characteristics of a cluster of patients with indistinguishable strains
The index case, patient A, was a 23 year old man who had recently arrived in the
United Kingdom from Brazil, and presented in June 1992 with productive cough,
fever and weight loss. He was admitted with a clinical diagnosis of right lower lobe
pneumonia and treated conventionally. An HIV antibody test was positive and his
CD4 lymphocyte count was 100 per JLl. When he had not responded to treatment a
week later he was transferred to Ward X of an HIV inpatient facility at Hospital 1.
The following day he had a bronchoscopy and bronchoalveolar lavage performed on
adjacent ward Y in a dedicated area separated from the main ward by a door. At that
time this area had an extractor fan that vented separately from the main ward, but not
negative pressure ventilation. Bronchoalveolar lavage fluid and sputum were positive




A cluster of cases with indistinguishable strains.
156110 RFLP analysis was repeated on DNA samples extracted from the
M. tubercuLosis isolates from patients A to D (Table 3.1.6).
Patient E, not known to be HIV seropositive, was a member of the control group and
was only recognised as part of this cluster at a later stage.
M: lambda Hind III molecular weight marker
anti-tuberculous therapy with rifampicin, isoniazid, ethambutol and pyrazinamide
several hours after bronchoscopy. M. tuberculosis fully susceptible to these drugs was
isolated from the samples. After three weeks he had improved and was transferred to
a convalescence unit. At follow-up after nine months therapy he had fully recovered.
Patient B was a 24 year old East African woman, found to be HIV antibody positive
two years previously, with a CD4 count of 30 cells per Ill. In April 1992 she
complained of fevers, sweats, weight loss and cough. Respiratory and microbiological
investigations were negative and she improved without systemic treatment. In June
1992 she was admitted to ward Y, one day prior to patient A, because of retinal
branch vein occlusion. Her chest X-ray at that time was normal and she was
discharged after one month. Eight weeks later she was readmitted to ward Y with a
short history of dry cough, diarrhoea, vomiting, anorexia and hepatomegaly. Chest
X-ray showed an enlarged right hilum and patchy shadowing in the right lower zone.
A right pleural effusion developed. Bronchoscopy and liver biopsy were performed
and acid fast bacilli were seen in both bronchoalveolar lavage fluid and liver tissue,
whereupon the patient was isolated and treated with rifampicin, amikacin,
ciprofloxacin and ethambutol. This was changed to rifampicin, isoniazid and
pyrazinamide when fully susceptible M. tuberculosis was cultured. Although her
tuberculosis responded to treatment, the patient died from other HIV-related problems
eight months later. A post-mortem examination was not performed.
Patient C was a 42 year old Caucasian man, HIV seropositive since 1986, with a
previous history of Pneumocystis carinii pneumonia (PCP). He was admitted to
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ward Y of Hospital 1 in May 1992 because of cough and breathlessness. A
bronchoscopy was normal and his CD4 count at that time was 30 cells per ,ul. In June
1992 he was readmitted to ward Y for investigation of weight loss and cough and he
was there until the day following patient A's admission. A chest X-ray was consistent
with past PCP but other respiratory and microbiological investigations were normal.
Cytomegalovirus retinitis was diagnosed and a Hickman line inserted. He was
readmitted in July 1992 because of neutropenia and Pseudomonas aeruginosa
bacteraemia, related to infection of the Hickman line. A month later he became
severely unwell with fever, hypotension and breathlessness and was transferred to the
intensive therapy unit where he died three days later. At post-mortem, oesophagitis,
shock lung and CMV colitis were found, in addition to a mediastinal lymph node,
histological examination of which revealed granulomata with acid fast bacilli. M.
tuberculosis was isolated from blood and urine collected shortly before the patient's
death.
The fourth patient, D, was a 41 year old man, HIV seropositive since 1985, who was
seen in the HIV clinic of Hospital 2 in February 1993 with a six week history of
cough, shortness of breath, fever, night sweats and weight loss. Shadowing in the
right mid zone was observed on chest X-ray, and at bronchoscopy, acid fast bacilli
were seen in bronchoalveolar lavage fluid. M. tuberculosis fully susceptible to first
line antituberculous drugs was subsequently isolated from his lavage fluid, sputum and
urine. He was commenced on standard antituberculous drug therapy with an adequate
response. The patient lived alone and had no known connection with any of the other
cases or with Hospital 1.
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Case E was a 24 year old man who worked as a staff nurse in Hospital 1. In August
1993 he presented with a short history of fever, cough and shortness of breath. A
pleural effusion was detected on examination, culture of which yielded M.
tuberculosis. This man, who was in good health prior to this episode, had no known
risk factors for HIV infection and was not advised to be tested for HIV antibody by
the clinicians managing his case. At the time of his illness he worked on the
adolescent oncology unit, which is less than 100 metres from Ward Y across a
courtyard. Patients from this unit sometimes received nebulised pentamidine on Ward
Y and were escorted there by nurses. However, Case E subsequently left employment
at Hospital 1 and it is not known whether he actually performed this duty. Nor are
records available from the nursing school to show whether he had a previous
attachment as a student nurse on the HIV unit.
In summary, five patients with strains of M. tuberculosis, indistinguishable on the
basis of RFLP typing and antimicrobial susceptibility were detected. Patients A, B
and C overlapped in their admission to the same hospital ward (Figure 3. 1.3) . Case
A presented with open pulmonary tuberculosis first, whereas cases Band C, both of
whom had very low CD4 lymphocyte counts, subsequently developed disseminated
tuberculosis within several weeks. Case E was a healthcare worker who worked on a
unit close to this ward and developed tuberculosis nearly 12 months later. No
epidemiological link was established between these cases and patient D.
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A cluster of cases with indistinguishable strains




Isolates of M. tuberculosis from patients not known to be HIV positive were
heterogeneous with regard to RFLP pattern (Figure 3.1.4). Apart from multiple
isolates from the same patient, which were indistinguishable by eye or Gelcompar
analysis, only two pairs of similar isolates from different patients were discovered.
However, these strains had only two and three copies of 186110 respectively, so that
RFLP analysis using a probe to this insertion sequence may not be adequate to
distinguish between such strains if they are genuinely unrelated. The patients involved
in these two pairs attended different hospitals.
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3.2 MYCOBACTERIUM AVIUM COMPLEX
56 AIDS patients with disseminated M. avium complex (MAC) infection were studied.
All had multiple isolates of MAC, including at least one from a blood culture or bone
marrow biopsy, sent between December 1991 and June 1994. The isolates from these
patients were referred from seven hospitals: Westminster/Chelsea and Westminster
Hospital (35 patients), University College Hospital (7), King's College Hospital (7),
Royal Sussex County Hospital, Brighton (3), Royal Free Hospital (2), St.
Bartholomew's Hospital (1) and St. George's Hospital (1). 53 of the patients were
male with a median age of 36 (standard error 7.0) years. Altogether, 210 isolates
were examined; almost all were viable after storage on Lowenstein-Jensen slopes at
room temperature for up to two years. 178 of these yielded sufficient DNA after
embedding the cells in agarose plugs to give adequate patterns on PFGE. The
breakdown of isolates in terms of the clinical specimens from which they were
cultured is given in Tables 3.2.1 and 3.2.2. Results were obtained for a median of
three isolates per patient (range 2 to 8).
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Table 3.2.1 Clinical specimens from which MAC isolates
used in this study were obtained.
Clinical specimen Number of specimens
1:1
Blood cultures and bone marrow 116 IIII








Table 3.2.2 Sites of MAC infection/colonisation
among the patients in this study.
Positive clinical specimen Number of patients




sputum/bronchial washing and faeces 6
other >I< 4
Total 56
... lymph node, liver, urine, pleural aspirate
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Preliminary experiments were carried out to optimise the yield of mycobacterial DNA
and the efficiency of restriction digestion prior to pulsed-field gel electrophoresis.
Difficulty was experienced initially in extracting sufficient DNA from the cells,
probably due to the lysis-resistant nature of the mycobacterial cell wall. Treatn1ent of
the harvested cells with the detergent Triton-X-I00 as recommended by Charvin et al.
(1991), or increasing the concentrations of lysozyme (to 2 mg/ml) and proteinase K
(to 1 mg/ml) used for cell lysis, or prolonging the incubation with these enzymes had
no effect on DNA yield (results not shown). The problem was overcome by
increasing the number of cells in each plug: resuspending each 10 ml culture in 200 JlI
buffer. Since this work was completed, some improvement in DNA yield has been
achieved with a variation of the method of Slutsky et al. (1994) by incorporating
0.5 M sucrose in the culture broth and resuspension medium, and by adding
ampicillin, D-cycloserine and D-threonine to the broth prior to harvesting (M.
Hunnable, personal communication). The concentration of restriction enzyme around
agarose plugs containing mycobacterial DNA was critical for efficient digestion. A
small volume (100 Jll) of buffer containing enzyme gave better results than the same
number of units of enzyme in a larger volume at a lower concentration.
Restriction digestion of chromosomal DNA with the enzyme Ase I resulted in a
median of 11 fragments (range 6 to 17) per isolate in the size range 50 to 700
kilobases. This gave rise to patterns which were easy to read and were highly
polymorphic, giving satisfactory discriminative power for comparing the patterns of
different strains (Plate 4). The large restriction fragment (LRF) patterns obtained
were reproducible from gel to gel under the same electrophoretic conditions.
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Plate 4 Ase I large restriction fragments of M. avium complex genomic DNA separated by PFGE.
Isolates from five patients, each with one strain of MAC throughout, which differs from that of the
other patients.
Lanes Patient Isolates from: Date
A 1-3 JM sputum, bone marrow, blood Oct. 93
A 4-6 CC liver, blood, sputum July-Oct. 93
A 7-9 AY bone marrow, sputum, blood Sept. -Oct. 93
B 1-5 WE stool, blood, lymph node blood (x2) Oct. 92-June 93
B 6-11 IS blood sputum stool blood urine tool Dec. 92-June 93
M: mol cular wight marker - lambda phage concatamers (48.5,97, 143.5 194 242.5 .... 1018.5
kiloba )
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Comparison of one pattern with another, both on the same gel and between different
gels, was facilitated by use of the same external markers (lambda phage concatamers)
on every gel. DNA migration from track to track across each gel was found to be
uniform with the CHEF DRII apparatus used, with little distortion at the ends of the
gels.
In 49 of 56 patients (87.5 %) all isolates obtained from the same patient had
indistinguishable LRF patterns. This applied both to isolates from different clinical
sites and also to those isolated at different times. The interval between receipt of
isolates for individual patients varied from 7 days to 30 months; in 7 cases intervals
of 12 months or more between isolates with indistinguishable LRF patterns were
observed.
The other 7 out of 56 (12.5%) patients were each infected or colonised with more
than one strain of MAC. Two patients had blood culture isolates which were different
to those cultured from other sites; three had strains from stool samples which differed
from those isolated elsewhere; one patient had both a blood and a stool strain which
were different to others; and one patient had a sputum isolate which was distinct from
his blood isolate. In each case, the patients with multiple strains from blood cultures
had consecutive infections with different strains, separated by intervals of between 11
and 21 months.
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Although the MAC strains isolated from most patients were unique to themselves, t\\'o
clusters of cases were discovered, one of eight patients and the other of four. in which
isolates with very similar LRF patterns were found in each case (Table 3.2.3,
Plate 5). When these strains were analysed with a different restriction enzyme, Xba I.
the same relationships were preserved (Plate 6). Initially five cases were recognised
in the first cluster. Because most of them had been referred from Westminster
Hospital during the second half of 1992, it was decided to examine all the MAC
strains from HIV patients referred from this laboratory between June and December
1992. This served to include patients from whom MAC was isolated on only one
occasion, or from sites which did not include blood or bone marrow (and were
therefore not included in the main study). 22 further patients were identified, of
whom three had a strain indistinguishable to that of the common strain. A limited
amount of information on these patients was disclosed by clinicians involved with their
care.
Six patients in the larger cluster had been inpatients at Westminster Hospital at various
times during 1992/3 and had also attended one or both of two units in London which
provide convalescence or terminal care to patients with HIV-related disease. In
addition, each of these patients had received chemotherapy for malignancy or retinitis
due to cytomegalovirus during the course of their illness. They were all registered at
different home addresses.
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Plate 5 Ase I large restriction fragments of M. avium complex genomic DNA separated by PFGE.
A Isolates from patients 3 (lanes 1-3), 8 (lanes 4-6), 4 (lanes 7-9), and 2 (lanes 10-12) in Table
3.2.3, showing part of a cluster of cases with indistinguishable strains.
B Isolates from patients I (lanes 1-3), II (lanes 4-6), III (lanes 7-9) and IV (lanes 10-12) in Table
3.2.3, showing strains with similar large restriction fragment patterns.
M: molecular weight marker (48.5 kilobase concatamers of lambda phage).
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Plate 6 Xba I large restriction fragment patterns of MAC genomic
DNA separated by PFGE.
Lanes 1 to 8: isolates from patients 1 - 8 in Table 3.2.3
Lanes 9 to 12: isolates from patients I - IV in Table 3.2.3
This confirms the relatedness of the strains shown in Plate 5.
M: molecular weight marker (48.5 kilobase concatamers of lambda phage).
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Table 3.2.3 Summary of patients whose strains of M. avium complex were
clustered by PFGE of large restriction fragments.
I Patient Age Source laboratory
'I •
I Slte(s) i Date
I
referred
1 NS I Westminster Blood 6/92
2 I 38 Westminster Blood, stool 7/92-10/92
3 I 39 King's College Blood, bone marrow, sputum 10/92-4/93
4 37 Westminster Blood, sputum I 11/92-12/92
5 NS Westminster Blood 12/92
I
I I
6 NS Westminster i Blood I 12/92
I 7 55 University College Blood* 1/93
8 31 Westminster Blood, sputum, stool 1/94-2/94 I
I 31 King's College
I
Blood, sputum I 11/93-5/94
II 33 King's College Blood 3/94-5/94
III 31 I Westminster Blood, stool 7/91-2/94
IV I 37 I Westminster Blood I, 12/93-6/94
* other, unrelated strains were also isolated from this patient between
October and December 1993.
NS: not stated
Patients I and II in the second cluster were acquaintances who had both been treated at
King's College Hospital for AIDS-related diseases at the same time. The PFGE
patterns of isolates from patients III and IV closely resembled but were not identical
to those of the other two on Ase I restriction digestion, although appeared to be the





At the time of the study, the Regional Tuberculosis Centre at Dulwich (now the PHLS
Mycobacterium Reference Unit) received mycobacteria for identification and
susceptibility testing isolated at over 70 client laboratories in South East England,
making up about 95 % of all isolates in the region. These laboratories included those
serving all but one of the large HIV units in London. The unit not covered (St.
Mary's Hospital) referred its isolates during the study period to a reference laboratory
in Cardiff where strains of M. tuberculosis were not routinely stored, and therefore
were not available for typing. Nevertheless, isolates from 24 other laboratories
referred between 1991 and 1994 were examined, so the collection is as representative
as possible of the M. tuberculosis strains causing infection in HIV patients in South
East England at that time.
In spite of the use of enrichment culture in liquid medium, the small proportion (11 %)
of strains of M. tuberculosis which were still alive after more than two years storage
on Lowenstein-Jensen slopes at room temperature was disappointing and limited the
number of strains and the time period covered by this retrospective study. Similar
findings have been made subsequently by others using strains from the same collection
(L. McKnight, S. Goss, unpublished observations). As a result, M. tuberculosis
isolates are now stored on Lowenstein-Jensen slopes at -2crC in the laboratory.
Reference collections elsewhere that are stored in this way have remained viable for
many years. A typing method involving a polymerase chain reaction to amplify very
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small amounts of DNA from the cells of non-viable strains or those giving an
inadequate yield in the initial DNA preparation step might overcome this problem. At
the time of the study, no single PCR-based method was generally accepted as
consistently reliable. Two techniques published subsequently which might be suitable
however, are spoligotyping of the spacers in the direct repeat region of the M.
tuberculosis chromosome (Kamerbeek et al. 1994), and heminested inverse peR
(Patel et al. 1996). The latter has been attempted with stored strains isolated from
tuberculosis patients in London during 1993 as part of a PHLS study.
Information on the HIV status of the patients from whom the strains were isolated was
provided by the referring laboratories. However, although patients with tuberculosis
in the control group were not known to be HIV seropositive, testing for HIV antibody
was not necessarily carried out, nor were risk factors for HIV infection ascertained.
It is therefore possible that some patients in this group may have been HIV positive
but not recognised as such. Although in theory the names of control patients could be
matched with those on the CDSC HIV database, information in the latter is recorded
in the form of date of birth and Soundex name code (a one-way coding system), so
this approach would still not enable all HIV seropositive 'controls' to be excluded
with certainty.
The median age of patients in HIV and control groups was similar, although the range
of ages was narrower for the HIV group, a higher proportion of which was male.
This reflects the predominance of young adult males in the HIV population of South
East England at present. Although used previously (Yates et al. 1993), the accuracy
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of inferring ethnic origin from surnames is very limited. For example, persons of
Caribbean or South American origin often have 'European' surnames, and surname
may be changed by marriage. A more reliable approach was used for the United
Kingdom 1991 Census in which people were asked about their ethnic group for the
first time. The Census provided much new data about ethnic minority groups in
Britain (A. Pozniak, personal communication), but its methods are not applicable to
this study. Nevertheless, it was observed that HIV seropositive tuberculosis patients
were much more frequently of presumed African origin than from the Indian
subcontinent, whereas the proportions of control patients in these two ethnic groups
were similar (Table 3.1.3). This is probably because HIV infection is more common
among African than among Asian people living in the region at present.
Comparison of the sites of tuberculous infection in the two groups showed that
although pulmonary disease was the most common form in both, extrapulmonary
tuberculosis was much more frequent among HIV patients. This finding is in
agreement with most other studies of tuberculosis in HIV infection (Barnes et al.
1991, 1993, Jones et al. 1993, Given et al. 1994). Isolation of M. tuberculosis from
blood cultures or bone marrow aspirates occurred only in the HIV group. Although
disseminated tuberculosis and mycobacteraemia are more frequent in HIV infection
than in immunocompetent persons, such cultures are also more likely to be taken from
HIV patients as part of the investigation of fever and weight loss, common in late
HIV disease. Positive stool cultures and gastric washings were also more common in
the HIV group, again possibly because such specimens are routinely submitted to
some laboratories as part of the investigation of other mycobacterial disease in HIV
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patients such as disseminated M. avium complex infection. In most of these cases
sputum isolates were also referred, suggesting that the main focus of infection was
pulmonary rather than the gastrointestinal tract. M. tuberculosis was also isolated
from urine samples more often in HIV patients than in the controls. This may reflect
the greater likelihood of disseminated infection in the former rather than disease of the
genitourinary tract, although full clinical details of most cases were not investigated.
Most isolates from HIV patients were fully sensitive to the first line antituberculous
drugs tested, although the proportion of these patients with an isolate resistant to one
or more drug (20/96, 20.6%) was higher than among the control group (7/84, 8.4%).
It was also higher than that reported for HIV seropositive patients whose strains were
referred to the Regional Tuberculosis Centre at Dulwich between 1984 and 1992
(Yates et al. 1993). During that period, 9 out of 162 (5.6%) patients had strains
resistant to one or more of the tested drugs, of which two thirds were of presumed
African ethnic origin. This was not significantly different from the rate of drug
resistance observed in the overall populations (Yates et al. 1993). Data on drug
resistance in M. tuberculosis isolated from HIV seropositive and seronegative patients
at 51. Mary's Hospital, London between 1987 and 1993 have also been published
(Taylor et al. 1995). In that series, 7.6% of 358 cases were resistant to rifampicin
and/or isoniazid, but almost all were from presumed HIV seronegative patients; no
increase in drug resistant isolates was observed over the period. Nevertheless, in
spite of the small increase in drug resistance observed in the present study strains
resistant to both rifamipicin and isoniazid (i.e. multidrug resistant tuberculosis,
MDRTB) were found in only two HIV patients. Both strains, isolated from sputum in
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one case and from urine in the other, were referred in 1994 from different hospitals
and had different RFLP patterns. In contrast, MDRTB affecting HIV patients was
widespread in the United States by 1991 (Snider & Roper 1992, Riley 1993, Haas &
Des Prez 1994) and had emerged in Italy at that time (Manno et al. 1991, Riley
1993).
This project involved setting up the equipment and protocols required for DNA
fingerprinting of M. tuberculosis in a clinical laboratory used to handling large
numbers of mycobacteria, but which compared different strains only on the basis of
phenotypic characteristics. The molecular techniques were used successfully, and
have subsequently been taught to other staff in the laboratory, who have used them to
investigate other collections of M. tuberculosis isolates. These include isolates from a
nosocomial outbreak of MDRTB at Chelsea and Westminster Hospital, described
below (M . Yates & R. Kent), isolates from tuberculosis patients in East London
during 1993-4 (L. McKnight), and isolates collected in a study in Nepal (E. Burke).
The typing system employed, RFLP based on the insertion sequence IS6110, was
valid for the strains tested in this study because all contained at least one copy of
IS6110 (100% typability), the patterns obtained were reproducible when multiple
strains from the same patient were typed or when the same strain was analysed on
different occasions, and the discriminative power of the typing method was high. The
latter is determined by the average number of copies of the repetitive element and the
degree of polymorphism of their position for the stains tested; both factors were high
in this study. RFLP analysis using IS6110 is most useful for isolates with unique
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fingerprints and for those in clusters which contain six or more copies of the insertion
sequence (Chaves et ai. 1996). These considerations applied to all the isolates from
HIV seropositive patients. However, the two pairs of isolates containing two and
three copies of IS6110, from patients in the control group, require a secondary probe
in order to determine whether or not they are genuinely identical. A probe to the
Direct Repeat sequence, or the polymorphic GC-rich repetitive sequence, or both,
would be suitable in this regard. Studies in which a significant proportion of isolates
possessed between two and five IS6110 copies have successfully used probes to these
repetitive elements to subdivide clusters (Alland et ai. 1994, Chaves et ai. 1996,
Strassle et ai. 1997).
A limitation of using a single probe in molecular epidemiological work is the
difficulty in interpreting the relationship between strains with very similar but not
identical fingerprint patterns. For example, strains with more than six copies of
IS6110 that differ from one another by only one or two bands on hybridisation may be
closely related if the difference has arisen through a transposition event on the
chromosome affecting the position of one of the bands. van Soolingen et ai. have
illustrated such a case occurring in a family outbreak of tuberculosis in
Czechoslavakia (van Soolingen et ai. 1991). However, analysis of sets of similar
isolates with pTBN12 shows that while most have indistinguishable patterns with this
probe, there are exceptions (Chaves et al. 1996). Strains with very similar but
different IS6110 patterns cannot necessarily be included in the same cluster, therefore.
For this reason, isolates in the present study were classified as either indistinguishable
or not. Although analysis of the RFLP patterns with GelCompar software generated a
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dendrogram showing apparent degrees of relatedness between isolates, it should be
noted that this is only a mathematical calculation and does not imply phylogenetic or
epidemiological relationships between them. Use of the Gelcompar system was not
altogether straightforward. For example, it sometimes separated isolates from the
same patient that appeared indistinguishable by eye. This was usually the case when
isolates were on different gels, run to slightly different distances, even though the
normalisation step of the analysis was supposed to take such factors into account. The
usefulness of Gelcompar depends on the number of isolates to be compared: for a
small number, comparison by visual inspection is probably satisfactory, whereas
computer assistance is required when there are many isolates. The best approach was
found to be an initial computer analysis to sort the isolates according to degree of
relatedness, followed by visual inspection of those isolates clustered together to
confirm or refute the computer assessment.
For 25 HIV patients who had multiple isolates of M. tuberculosis the results of IS6110
RFLP .analysis were consistent in each case with infection due to a single strain. In
some patients, infection with one strain at multiple sites was due to disseminated
disease. Relapse of infection with the same strain was less likely in most cases
because of the short time intervals between receipt of these multiple isolates. No
evidence for infection with more than one strain per patient (re-infection) was
obtained. The RFLP data also show that in one patient the development of
pyrazinamide resistance was consistent with acquisition of resistance by the original
strain and not to fe-infection with a different strain. It should be noted however that
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susceptibility testing of M. tuberculosis to pyrazinamide is much less straightforward
than for other antituberculous drugs (section 2.1.2). False resistance to pyrazinalnide
is sometimes seen, but tests on isolates appearing resistant are repeated. Strassle
et al. (1997) studied a cohort of 46 HIV patients with tuberculosis in Zurich,
Switzerland, and also found that among the patients from whom multiple isolates were
available, the IS6110 patterns remained virtually stable over a period of up to four
years as well as during the emergence of drug resistance. No evidence for reinfection
of a patient with a different strain was obtained.
Comparison of the DNA fingerprint patterns obtained by IS6110 RFLP analysis
showed considerable heterogeneity among the strains isolated from HIV seropositive
patients. 12 of the 96 patients belonged to one of four clusters of indistinguishable
strains. From these figures, 8 patients (8.2%) may have acquired tuberculosis from
recent person-to-person transmission rather than by the reactivation of latent infection.
This proportion is significantly higher than in the control group, where no clusters of
cases were found, if strains containing three or fewer copies of IS6110 are excluded
from analysis (p < 0.001 in chi-squared test with Yate's correction).
Nevertheless, published studies of tuberculosis transmission in some other countries
suggest that the proportion of cases due to recently acquired infection is higher than
this: at least a quarter of cases in Denmark (Yang et aI. 1995a) and a third or more
in New York City (Alland et al. 1994) and San Francisco (Small et al. 1994). One
explanation for the lower proportion observed here is that the patients were from a
wide geographical area (South East England) and were heterogeneous with regard to
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socioeconomic group and ethnic origin. About a third of HIV seropositive
tuberculosis patients were of presumed African origin (Table 3.1.3); many of these
may have acquired their original infection abroad before coming to live in the region.
Increased patient diversity is expected to be associated with heterogeneity of infecting
strains. A French study in which clinical isolates of M. tuberculosis from patients
attending selected hospitals in Paris during 1993 were systematically typed using
156110 RFLP analysis and other methods, supports this conclusion (Torrea et al.
1996). Only 13 % of cases were thought to have had recently transmitted tuberculosis,
but three quarters of the patients were said to be foreigners from various parts of the
world including Africa and Asia.
Direct comparison of the results with other studies of tuberculosis transmission
abroad, however, may be misleading because only strains from HIV seropositive
patients and from selected controls were typed here, whereas most studies have
examined all strains isolated in a given community over a particular time period. It is
likely that clusters of cases resulting from person-to-person transmission of M.
. J
tuberculosis would have been unoticed had transmission occurred from an HIV
positive case to an HIV negative person not included in the study, or vice-versa. In
order to avoid underestimating the extent of recent transmission in a community it is
therefore necessary to type all strains isolated from patients with tuberculosis. Such a
study has been set up by the PHLS Communicable Disease Surveillance Centre to
examine all available strains isolated during 1993 from patients with tuberculosis in
South East England, and is using some of the isolates studied here. Nevertheless, if
time and resources allow only a sample of cases to be studied, then infection in HIV
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positive patients is likely to be the most sensitive indicator of the spread of
tuberculosis. HIV seropositivity is a clear risk factor for belonging to a cluster of
cases in other studies (Hamburg & Frieden 1994), partly because of the increased
susceptibility of these patients to developing clinical disease after infection and
because they are frequently looked after together in special HIV units, both in and out
of hospital, where aerosol-generating procedures are also performed.
The cluster of cases described in this study (patients A to E) illustrates some of these
points. Cases A, Band C were epidemiologically related: patients B and C were
present on ward Y of the hospital concerned at the time that patient A, who was
sputum smear positive, was bronchoscoped there. At that date, the bronchoscopy
room, which opened directly on to ward Y, did not have negative pressure ventilation.
Although the period of time spent by patient A on ward Y was short, it included this
cough-inducing procedure. In addition, the two wards X and Yare connected by an
atrium, and patients from each ward use facilities on the other. The three patients had
no known contact with each other apart from admission to this hospital. Taken in
conjunction with the results of RFLP analysis on the strains, there is sufficient
evidence to conclude that transmission of tuberculosis occurred from patient A to
patients Band C (Kent et al. 1994, Miller et al. 1995). The latter were severely
immunocompromised and developed pulmonary and!or disseminated tuberculosis
within several weeks of exposure to the index case. Case E is probably linked to
these three. Although his illness was apparent approximately 12 months later, he was
a healthcare worker on a unit close to Wards X and Y in the same hospital. It is
possible, although it cannot be proven, that contact with patients A, Band C may
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have occurred.
The relationship between these cases and patient D is unknown however. The latter
resisted attempts at contact tracing. It is possible that an unidentified intermediate
patient who was HIV negative and therefore not studied, or whose strain was not
referred to the laboratory, or was non-viable, may have acted as a link between the
first cases and this man. Transmission could have occurred in a public place such as
a bar, between individuals who did not know each other. This scenario was suggested
to be the link between several cases in the community outbreaks of tuberculosis
investigated in King County, Washington (Tabet et al. 1994) and in Berne,
Switzerland (Genewein et al. 1993). Conventional contact tracing again failed to
identify the routes of transmission in these outbreaks.
Although epidemiological information clearly links patients A to C, further molecular
work using more recently described methods might be able to resolve whether patients
D and E should be included in the same cluster. RFLP analysis of the direct repeat
region (Torrea et al. 1995) and of the domains which hybridise to oligonucleotide
(GTG)s (Warren et al. 1996) both appear to have the ability to subdivide clusters of
strains with indistinguishable high copy IS6110 patterns, and would be suitable in this
regard.
This cluster of cases would not have been recognised if isolates of M. tuberculosis
from HIV patients had not been routinely stored in the laboratory and without the use
of RFLP typing. The recognition and investigation of future outbreaks would be
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greatly facilitated if all strains are typed upon referral to reference laboratories, as
opposed to selected isolates as part of a retrospective investigation. Projects to do this
have been set up elsewhere, including New York City and the Netherlands. On a
larger scale, a concerted action to collect fmgerprints from many European countries
and store them in a database together with clinical and bacteriological information has
been initiated (Small & van Embden 1994). It is anticipated that this will eventually
be able to provide clues about the impact of, for example, HIV, migration, drug
resistance and BCG vaccination on tuberculosis transmission within Europe.
The hospital outbreak of tuberculosis uncovered in this investigation was the first to
be described among HIV patients in the United Kingdom. It was suggested at the
time that units caring for such patients should review their procedures and policies for
managing cases of suspected tuberculosis and preventing its transmission (Kent et ai.
1994). Suitable guidelines for limiting the spread of airborne pathogens have been
published by the Centers for Disease Control, Atlanta (1990, 1994). Although
expensive to implement fully, there is agreement that stricter protocols to control the
transmission of tuberculosis should be adopted in HIV units (Scott & Holton 1994).
In spite of this however, two further outbreaks have subsequently come to light in
HIV units in London. Potentially these are more serious because they involve
multidrug resistant strains of M. tuberculosis. In one, a 33 year old Portuguese man
was admitted to a six bedded bay of the HIV ward at Chelsea and Westminster
Hospital with a diagnosis of Pneumocystis carinii pneumonia (CDSC 1995b, Hannan
et ai. 1996). At that time (April 1995) he was taking quadruple antituberculous
therapy, but one month later M. tuberculosis resistant to rifampicin, isoniazid,
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pyrazinamide, rifabutin, clofazimine and ethionamide was cultured from sputum.
Four patients in the sam,e bay as the index case developed active tuberculosis within
eight weeks of exposure, and their isolates had the same susceptibility and RFLP
patterns. As a result of this outbreak local guidelines for the diagnosis and
management of HIV-associated MDRTB were drawn up by a committee of local
clinicians (London Communicable Disease Monitor, October 25th 1995, Insert 4).
The second outbreak of MDRTB, announced by the Chief Medical Officer in June
1996, occurred in at least four HIV positive patients at St. Thomas's Hospital
(CaIman 1996). Investigations are continuing, but several of the patients were
infected with strains showing the same drug resistance and RFLP patterns. The
Department of Health is currently preparing guidelines for the management of
suspected cases of MDRTB.
It is regretable, despite the extensive and widely reported experience of nosocomial
transmission of tuberculosis among HIV patients in the United States and elsewhere,
that many units caring for this group of patients in the United Kingdom do not enforce
adequate policies and procedures to prevent transmission until after such an event has
occurred. It is important that health care workers should maintain a high index of
suspicion for tuberculosis in view of the frequently atypical presentation in HIV
infection. Any patient with respiratory symptoms attending such a unit should be
regarded as potentially having MDRTB until proved otherwise. These cases should be
managed in single rooms with negative pressure ventilation and proper enforcement of
isolation procedures. It is crucial that all aerosol-generating procedures such as
bronchoscopy must be carried out in a separate, adequately ventilated area. Staff
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should have evidence of delayed hypersensitivity to purified protein derivative before
working on the unit, and staff who are themselves HIV positive should not work with
these particular patients. Wherever possible, antituberculous therapy should be
directly supervised to prevent the emergence of MDRTB, both in hospital and in the
community.
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4.2 MYCOBACTERIUM A VIUM COMPLEX
This study was an attempt to investigate the natural history of disseminated MAC
infection in AIDS by typing isolates from patients with positive blood or bone marrow
cultures. These sites were chosen because isolation of MAC from sputum or stool
samples alone may reflect colonisation with the organism rather than disseminated
infection. Patients with more than one positive culture were selected first to enable
comparison of organisms isolated at different times or from different body sites in the
same individual. This policy served to exclude patients with transient bacteraemia,
who may not be representative of those with established disseminated infection
(Kemper et al. 1994). It also reduced the likelihood of inadvertently studying false
positive cultures which might have resulted from cross contamination of specimens
from different patients in one of the source laboratories. Pseudo-outbreaks of MAC
have been described in several laboratories (which did not provide isolates used in this
study) where carry-over contamination from positive to subsequent negative culture
bottles occurred in BACTEC 460 TB systems (Vannier et at. 1988, Bignardi et at.
1994, Burki et al. 1995). In each case this was thought to have resulted from
inadequate heating of the needle used to sample each bottle between cultures~ even a
needle temperature of 240. 7°C, below the required temperature of 250 to 30crC, was
associated with carry-over contamination on one occasion (Burki et al. 1995).
The patients whose isolates were studied were predominantly young men. This
reflects the population of patients with disseminated MAC infection seen at the Il1ain
source hospitals. After blood and bone marrow cultures, MAC was isolated more
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often from sputum than from stool samples in the patients selected. This is in spite of
the fact that stool samples are more often cultured for MAC as part of routine
investigation protocols in many HIV care centres. It may reflect the relative ease of
culturing mycobacteria without contamination from sputum compared to stool
samples, rather than the true frequency of MAC in the gut or respiratory tract of these
patients. Many clinical laboratories employ a method designed to reduce
contamination by microorganisms present in the normal flora of such specimens, for
example by incubating them briefly with strong alkali before culture (Collins et al.
1985). Such treatment will reduce the numbers of mycobacteria present in the sample
by at least 5 to lO-fold, while killing other bacteria and yeasts to a greater extent.
However, the compromise is more difficult to achieve in practice for stool specimens
than for respiratory tract specimens which are usually less heavily contaminated.
In most cases, the intervals between receipt of different isolates from an individual
patient were generally quite short. This may be expected since disseminated MAC
infection usually occurs towards the end of the course of HIV infection when CD4
lymphocyte counts are low and life expectancy is short (section 1.3.1). Surprisingly,
however, multiple isolates of MAC were received over a long period of time, up to
30 months, in a significant proportion of cases, and typing showed that the same
strain (per patient) was responsible for persistent infection throughout. As discussed
below however, the possibility of polyclonal infection in these patients, with the strain
isolated representing the one best adapted to growth in vitro, was not excluded. The
strains from patients with chronic infections had different PFGE types suggesting that
a common strain of reduced virulence was not responsible. However, relatively little
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is known about virulence factors in MAC (section 1.3.4), and such factors would not
necessarily correlate with DNA restriction sites. Host factors that might predispose to
persistent MAC infection are worthy of further study. These include HIV viral load
and CD4 lymphocyte count at the time of infection, the level of tissue involvement
and bacteraemia (colony forming units per gram or ml), although the latter does not
correlate closely with symptoms in individual patients, and the presence of other HIV-
associated disease.
Although stored under the same conditions, the viability of the MAC isolates on
subculture was much better than that of the M. tuberculosis isolates. No correlation
was found between the chance of successful subculture and the age of the stored
slope. This means that libraries of MAC isolates may easily be stored for future
studies. The apparently superior survival of MAC under conditions of nutrient
limitation in vitro is probably related to the cell wall structure of this species. The
mycobacterial cell wall and envelope contains several insoluble macromolecular
components: arabinogalactan, peptidoglycan and mycolic acid, as well as
lipoarabinomannan and, specific to MAC, the glycopeptidolipids which confer
serological specificities. The complex array of hydrocarbon chains of some of these
components is likely to be responsible for the impenetrability of the cell wall
(Inderlied et al. 1993). This, in turn, may explain the ability of organisms of the
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MAC to survive in the environment. It may also account for intrinsic resistance to
many antimicrobial drugs which are unable to penetrate into the cell (Rastogi &
Barrow 1994), and for the difficulty in achieving cell lysis when attempting to extract
intact mycobacterial DNA. The relative heat resistance of MAC, exemplified by
123
pseudo-outbreaks that have occurred in association with inadequate heating of
sampling needles in BACTEC systems (Vannier et al. 1988, Bignardi et al. 1994,
Burki et al. 1995), may also be due in part to the cell wall structure.
As other studies have shown, PFGE of the large restriction fragments generated by
restriction digestion of chromosomal DNA with Ase I gave rise to a high degree of
polymorphism among clinical isolates of MAC (Arbeit et al. 1993, Mazurek et al.
1993) . This technique is highly discriminating for use as a typing method, in contrast
to RFLP analysis using the probe pMB22 which appears to recognise only a limited
number of strains (Hampson et al. 1989, Visuvanathan et al. 1992). The considerable
genetic diversity of MAC isolates from AIDS patients is compatible with the
hypothesis that infection is acquired from environmental sources. Since the laboratory
work for this study was completed, RFLP analysis using the insertion sequence
IS1245 has been shown to generate a suitably high number of copies and a diversity of
patterns comparable to that obtained with PFGE for human strains of M. avium
(Guerrero et al. 1995). In view of the difficulty in reliably achieving lysis of the cell
wall to obtain intact genomic DNA in this species, and the lack of a stable end
product with PFGE (that is, an agarose gel rather than DNA cross-linked to a nylon
membrane), IS1245 RFLP analysis may prove to be a more popular method for future
studies involving typing of M. avium strains. However, its value will depend on the
number of copies and heterogeneity of postition of IS1245 in the particular collection
of strains under investigation. For example, von Reyn et al. (1996) have encountered
epidemiologically unrelated strains with distinct PFGE profiles but indistinguishable
151245 RFLP patterns containing three or fewer copies of the insertion element. As
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with RFLP methods using other probes, if a high proportion of strains contains few
copies then other methods will be required to subdivide isolates which appear to
cluster together.
Guidelines for interpreting chromosomal DNA restriction patterns produced by PFGE
in the context of bacterial strain typing have been published (Tenover et ai. 1995).
These are most relevant to comparatively small sets of isolates related to putative
outbreaks of infection. Isolates are designated as indistinguishable if their restriction
patterns have the same number of bands of the same apparent size. They are closely
related if two or three fragments differ compared to the outbreak pattern; such
changes result from a single genetic difference compared to the outbreak strain, for
example a point mutation leading to gain or loss of a restriction site, or the insertion
or deletion of DNA in an existing fragment. Strains with two genetic differences have
four to six fragment differences compared to the outbreak strain and are regarded as
only possibly related to the latter. In this study, however, almost all isolates appeared
to be either unrelated or indistinguishable to each other.
PFGE has been criticised previously for poor reproducibility from one experiment to
another (Saunders & Ridley 1994), but this was not found in this study. Under the
same electrophoretic conditions (voltage, duration, switch times) and composition of
buffer and gel, a strain of MAC gave reproducible patterns from gel to gel.
However, only one apparatus was used here by one operator, so the reproducibility of
the method in different laboratories remains to be established. There is a need for a
standardised methodology so that results from different laboratories may be compared,
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as has been established for 156110 RFLP analysis of M. tuberculosis. If libraries of
stored MAC strains are established, application of the standardised methodology may
then lead to a greater understanding of the molecular epidemiology of this infection.
Typing multiple isolates of MAC from the same patient could suggest clues about the
pathogenesis of this infection. For example, isolates from different body sites that
appear to be the same strain by typing are likely to be the result of disseminated
infection. Isolation of a strain from a superficial site such as the gastrointestinal or
respiratory tract before it is subsequently isolated from blood cultures, is consistent
with colonisation of the site preceding invasion and disseminated infection. However,
a prospective study in which frequent cultures from different body sites are made, in
susceptible patients without a previous history of MAC, is really required to be able
to draw valid conclusions about pathogenesis. In the present study, isolates were not
necessarily referred by source laboratories in the same order that cultures were taken
from the patients. This may be because, for example, a blood culture inoculated into
liquid medium usually yields growth before a sputum sample taken at the same time,
but cultured on solid medium after a decontamination step likely to reduce the number
of viable organisms present. From a minority of patients, two or more genotypically
different strains of MAC were isolated. In this group stool isolates rather than those
from respiratory tract samples more frequently differed from the blood/bone marrow
isolates. This observation supports the view that colonising strains and those
responsible for disseminated infection in the same patient may be different, which is
not surprising if there is continual exposure to multiple strains in the environment.
Havlik et al. (1994) have demonstrated that screening cultures for patients at risk of
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disseminated MAC infection have little predictive value because in some cases
colonisation may not be detected before dissemination occurs, and in others
established colonisation does not progress to dissemination. Although numbers are
small, one interpretation of the above results is that strains colonising the respiratory
tract are more likely to lead to disseminated infection than those present in the gut.
An alternative hypothesis is derived from autopsy findings in 44 AIDS patients with
MAC bacteraemia (Torriani et at. 1994). 30% of these patients had no histological
evidence of MAC and the risk of developing detectable tissue involvement was
proportional to the duration of bacteraemia. The authors favoured the view that
invasion of a mucosal surface by MAC is followed by transient bacteraemia during
which the organism is seeded in multiple organs eventually giving rise to extensive
tissue disease and increasing levels of bacteraemia. If this is the case, organisms
present in say the lungs may represent the eventual target rather than the original
source of the infection.
Several studies in the United States have concluded that polyclonal infection with
MAC, that is two or more different strains simultaneously causing disseminated
infection, is common among patients with AIDS (Arbeit et at. 1993, Slutsky et ai.
1994). Although unequivocal evidence for polyclonal infection was not obtained in
this work, it is possible that use of stor,ed slopes of referred isolates rather than
primary cultures may have underestimated the occurrence of this phenomenon. In
order to detect polyclonal infection clinical specimens need to be plated on primary
isolation media in such a way that the individual colonies subsequently grown can be
picked off for subculture and typing independently. Mixed cultures are not readily
127
apparent when growth is confluent on Lowenstein-Jensen slopes. (The same criticism
could also be made of cultures of M. tuberculosis referred to the laboratory.
However, there is little evidence to suggest that polyclonal infections are common in
tuberculosis.) Furthermore, most of the source laboratories in this study employed
liquid media (such as BACTEC) for culturing blood rather than solid media (as in the
Dupont Isolator lysis centrifugation system). It is possible, as von Reyn et al. (1996)
have discussed, that when two strains of MAC are inoculated together into a liquid
medium, one may compete more effectively and grow more rapidly at the expense of
the other, giving the impression of a single strain by the time that the threshold of a
positive growth index is reached in the bottle. Primary isolation on solid media is
also important for drug sensitivity testing, because in a polyclonal infection
overgrowth by a susceptible strain in liquid culture may potentially mask the presence
of a second drug resistant strain. In a small number of patients, isolates from positive
blood cultures referred several months apart were genotypically different. These were
thought to be consecutive rather than true polyclonal infections, as the different strains
were not present simultaneously. However, it is possible that sampling error resulted
in the recovery of a different strain on each occasion from a polyclonal bacteraemia.
Two clusters of cases infected with indistinguishable MAC strains were discovered.
Epidemiological information about the patients involved is incomplete, but in the
larger cluster, patients had attended several hospitals and two different convalescence
hotnes and no single common factor could be identified. Furthermore, many other
AIDS patients attended these units over the same time period but were infected with
different strains of MAC. Most of the patients in the cluster had received
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chemotherapy for cytomegalovirus retinitis or malignancy. This would have resulted
in further immunosuppression, perhaps increasing the susceptibility of the patients to
disseminated MAC infection. However, other patients undergoing these treatments
were not infected by the same strain of organism.
A study of MAC strains isolated from 129 patients in Berne, Switzerland, although
uncovering significant problems due to cross-contamination in a BACTEC system,
reached similar conclusions with regard to the diversity of genuine MAC isolates in
the community (Burki et al. 1995). Most patients had unique strains as judged by
PFGE pattern. However, several clusters of two and three cases were noted, as well
as a group of eight HIV patients from whom a strain with the same PFGE pattern was
isolated, mostly from respiratory tract specimens. Further epidemiological
information on this group was not given however. The particular strain was estimated
to account for one fifth of MAC isolated from HIV patients in that area (Burki et al.
1995).
The long interval of approximately 18 months between the first and last identified
cases in the larger cluster of eight cases could be explained by continuing exposure of
susceptible patients to a common source of the 'outbreak' strain. Recirculating hot
water systems were suggested to be such a source in two small groups of patients (3
and 2 cases respectively) at two hospitals in Boston and New Hampshire (von Reyn et
al. 1994). The hot water systems at these institutions were found to be persistently
colonised with the same strain of MAC responsible for disseminated infection in the
patients concerned, who had had numerous possible exposures to hospital hot water.
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Ideally, water samples from the hospitals and convalescence units attended by cases in
the present study would be cultured for mycobacteria, to see if the same strain of
MAC could be recovered. However, water samples are not available from the
hospital which treated the majority of these patients (Westminster Hospital) which \\'as
closed in 1993 when the unit moved to new premises. This may be a suitable area for
further study, especially as it has been suggested that disinfection of hospital hot water
distribution systems may prevent some MAC infections in AIDS patients (Singh & Yu
1994, von Reyn et at. 1994). As exposure to multiple sources of MAC in the
environment is the rule for most persons, such a measure cannot be expected to
prevent all infections. However, the alternative of prophylaxis with antimycobacterial
drugs such as clarithromycin (Pieroe et ai. 1996), azithromycin andIor rifabutin
(Havlir et at. 1996), while improving survival may also lead to adverse effects,





The pandemic of HIV infection has had considerable impact on disease caused by
mycobacteria. In some parts of the world notifications of tuberculosis have risen
largely as a result of immunosuppression caused by HIV. Differences in the
presentation of tuberculosis, including the prominence of extrapulmonary disease and
accelerated progression of infection are also apparent. M. avium complex, a
previously somewhat neglected organism, has also come to prominence as
disseminated infection by this organism is a common opportunistic infection in AIDS
patients and is seen almost exclusively in them. While the mode of transmission and
pathogenesis of tuberculosis are well understood (although the extent of reactivation
versus recent transmission among HIV patients in the United Kingdom has received
less attention), such fundamental aspects of MAC infection remain to be fully
established.
Building a library of stored isolates from patients and analysing them with an
appropriate genotyping method is one approach to improve understanding of the
molecular epidemiology of these infections. In this study, isolates from HIV patients
referred from laboratories in South East England to Dulwich Public Health Laboratory
between 1991 and 1994 were used. The viability of M. tuberculosis strains stored on
Lowenstein-Jensen slopes at room temperature was found to be low after two years.
Strains are now stored at -20°C as a result. By contrast, MAC isolates survived well
at room temperature.
RFLP analysis with a probe to insertion sequence IS6110 was used for M.
tuberculosis and was easily set up in a clinical laboratory which handles primary
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isolates and referred strains of this organism. PFGE of Ase I large restriction
fragments was used as the method for typing MAC. Both methods were reproducible
and had adequate discriminatory power for the strains studied. 156110 RFLP analysis
has the advantage that a standardised methodology has been agreed, enabling
comparison of results between different laboratories and the potential for establishing
a computer database of results. If PFGE is to become established as the main method
for typing MAC, standardisation of the methodology will be required.
Isolates of M. tuberculosis from 96 HIV seropositive patients and 84 controls were
examined. As expected, those from HIV patients were more often from
extrapulmonary sites compared to the control group. Resistance to one or more first
line antituberculous drugs also occurred more frequently among the isolates from HIV
patients. However, only two strains resistant to both rifampicin and isoniazid (that is,
MDRTB) were encountered in this group, from unconnected patients. 156110 typing
revealed considerable heterogeneity among the isolates from HIV patients, and the
most likely explanation for this is the diversity of social and ethnic origins of such
patients living in South East England, many of whom acquired their original M.
tuberculosis infection elsewhere. Nevertheless, four clusters of cases, involving a
total of twelve patients, with strains having indistinguishable RFLP patterns were
observed. This was significantly more than among the control group and suggests that
recently transmitted infection is responsible for clinical disease more frequently in
HIV patients. This conclusion is consistent with the findings of studies in other parts
of the world. In the largest cluster of five cases epidemiological information
supported the conclusion that nosocomial transmission of tuberculosis had occurred
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from one HIV patient to two others. A healthcare worker at the same hospital, who
was not known to be HIV positive, later presented with clinical disease due to the
same strain. This was the first outbreak of tuberculosis in an HIV care centre
described in the United Kingdom. These clusters of cases all involved drug sensitive
strains, but two outbreaks of MDRTB in London have subsequently been reported.
56 AIDS patients with disseminated MAC infection were studied. Ase I large
restriction fragments of the strains isolated from different patients showed
considerable heterogeneity. This is consistent with the findings of other studies that
have used PFGE to type isolates of MAC. Most of the patients who had isolates from
more than one body site, as well as those in whom infection persisted for twelve
months or more, had the same strain throughout. No cases of concurrent polyclonal
infection were seen. However, the use of cultures from stored slopes in this study
together with the widespread employment of liquid culture media for detecting
disseminated MAC infection in referring laboratories means that the proportion of
cases with polyclonal infection may be underestimated. A prospective study involving
frequent surveillance cultures from patients at risk of disseminated MAC infection,
with typing of individual colonies isolated on solid media, is required to further
elucidate the pathogenesis of this condition. A cluster of eight patients with
indistinguishable MAC strains was observed, although insufficient epidemiological
information was available to confirm that this was due to an outbreak of infection.
An important aim of molecular epidemiological work is to apply the results in order to
prevent future infection in susceptible individuals. For M. tuberculosis, it is clear that
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attention to infection control precautions, in particular isolation of patients suspected
of having pulmonary tuberculosis and the use of rooms with negative pressure
ventilation for performing aerosol-generating procedures, is the key to controlling
transmission of infection. If further evidence is obtained of common sources of
MAC, such as hospital hot water supplies, appropriate treatment of these sources may
prevent a proportion of MAC infections in AIDS patients. As the organism is widely
present in the environment however, chemoprophylaxis may be a more effective
alternative at present.
Many unanswered questions remain, particularly regarding the pathogenesis of
disseminated MAC infection, which is a deserving area for future research.
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